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ABSTRACT 
Although bipolar disorder was one of the earliest described mental illnesses, there is a 
dearth of research on bipolar disorder in individuals with intellectual deficits. The present study 
aimed to extend this literature by comparing the presence and variation of manic symptoms over 
time of persons with intellectual deficits with and without bipolar disorder. Three groups of 
individuals participated: a bipolar group, a psychopathology group (other than bipolar disorder) 
and a control group. Two dependent measures of mania were taken from retrospective data, 
Mania subscale of the DASH-II and a Criterion-referenced subscale. The presence and 
consistency of mania symptom endorsements were analyzed over time and across groups. 
Results indicated that the bipolar group had greater mean endorsements on the Criterion-
referenced subscale than the psychopathology and control groups.  Further, manic symptom 
endorsements were more stable over time in the bipolar group than the other two groups. This 
pattern of serial correlations was inconsistent with hypotheses. These findings are tempered by 
the fact that the patterns of serial correlations in comparative anchor subscales were also 
unanticipated. In order to clarify these unexpected findings, research is needed to examine the 
accuracy of staff to report the frequency of symptomology. 
 iv
INTRODUCTION 
With recent advances in pharmacological treatment, bipolar disorder has come to the 
forefront of clinical research. Although bipolar disorder is by no means a new disorder, very 
little is known about how it is manifested in individuals with intellectual disabilities (ID). The 
present study aims to investigate the presentation of manic symptoms in individuals with ID. A 
brief overview of the history of ID, dual diagnosis, bipolar disorder, and the comorbidity of 
bipolar with ID will be discussed.  
History of Intellectual Disability 
Throughout history there have been individuals deemed less or more capable than others. 
Over time, the view of the less capable individual has changed with the needs and expectations 
of the society (Scheerenberger, 1983). Historians suggest that infanticide was a common practice 
before and during the middle ages. That is, individuals with deficits or physical handicaps 
preventing them from hunting, gathering, or keeping with expectations of the society were often 
killed at birth or died at an early age. However, those with mild deficits who were able to 
contribute to their community probably survived (Scheerenberger, 1983).  
During the middle ages, more attention was given to those with physical abnormalities 
and other medical problems such as hydrocephaly and epilepsy (Ruhrah, 1925). It was not until 
the sixteenth century that the Swiss physician Paracelsus made a distinction between ID and 
mental illness. Platter, another Swiss physician, was the first to offer a multi-level description of 
ID. Although ID was given more attention and recognition by the physicians of the time, the 
condition was deemed untreatable (Scheerenberger, 1983).  
The seventeenth and eighteenth centuries were marked with significant advances to 
science, medicine and, thus, the understanding of ID. The term idiocy had become the commonly 
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accepted scientific term of ID. Philosophers of this time, such as John Locke, had a great impact 
on human thinking and the treatment of individuals with ID. Locke’s empirical theory of 
knowledge, which stated that the mind is a blank table (tabula rasa) at birth and that ideas come 
from experience, provided a basis for the treatment and training for individuals with ID (Murphy, 
1949). Locke also recognized the difference between idiots (ID) and madmen (mental illness; 
Doll, 1962).  
Considerable progress was made to understand ID and identify associated illnesses in the 
nineteenth century. Physician W. J. Little was the first to draw critical attention to the potential 
deleterious effects of premature birth, difficult labor, and mechanical injuries during delivery and 
hypoxia. Little’s research played a vital role in emphasizing the importance of prenatal and 
perinatal care. J. Langdon Down also highlighted the importance of the emotional health of 
childbearing women. Additionally, Down advanced the treatment and the education of 
individuals with ID (Scheerenberger, 1983).  
The works of Jean Etienne Domique Esquirol and Edouard Seguin furthered the concept 
of the differentiating degrees of ID. Esquirol made a distinct contrast between amentia (ID) and 
dementia (mental illness). He also divided those with ID into two levels: the imbecile and the 
idiot (Scheerenberger, 1983). Seguin was the student of Itard, the first to develop a broad 
educational program for a child who was deaf and mute. Seguin was sensitive to the varying 
levels of functional behavior among persons with ID. He divided idiocy into four broad 
categories: idocy, imbecility, backwardness or feeblemindedness, and simpleness or superficial 
retardation. Seguin’s physiological method, a systematic training of the senses, was an 
educational approach that had a great impact on the education of those with ID. Many of the 
ideas and techniques (i.e., simple movements, imitation and generalization) of this method are 
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still employed in current treatments, such as positive reinforcement procedures and modeling 
(Scheerenberg, 1983). As Seguin advocated for the education of individuals with ID, he also 
emphasized the importance of their moral treatment (Talbot, 1964).  
At the turn of the century, the interest in ID soared. Many organizations, publications, 
and programs were established in the interest of those with ID. In 1876, the first meeting of the 
American Association on Mental Deficiency (AAMD) was held. The following year, 1877, the 
AAMD officially announced the first definition of ID. By the twentieth century, the three 
essential components of a definition of ID were well recognized as: 1) early onset; 2) reduced 
intellectual functioning due to developmental disorder; and 3) an inability to adapt to the full 
demands of society (Scheerenberger, 1983). 
Not only was this a time for professionals to gather to discuss and study the etiology and 
prevalence of ID, but also a time when the services for these individuals were formulated. In 
1911, New Jersey passed the first state law requiring the mandatory special education of children 
with mild ID. The goal of these classes evolved from simply removing the most difficult or 
trying from the regular classroom, to raising the moral tone of children, making them more 
capable in their family life, and later to focusing on academic work and physical education 
(Sheerenberger, 1983). 
Eligibility for special education classes soon came into question. Thus, the need for 
psychological and intellectual measurement increased. The Binet-Simon Individual Tests of 
Intelligence, the first intelligence test, appeared in 1905. This version was intended to distinguish 
between subnormal and normal school-aged children, and it was interpreted in terms of the three 
levels of ID: idiocy, imbecility, and moronity (Scheerenberger, 1983). Although the early part of 
the century can be characterized as an increased sensitivity to those with ID, there were also 
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several restrictive measures taken. Laws were passed that prohibited the marriage among the 
intellectually disabled. Sterilization was another measure pursued to prevent reproduction of 
those with ID, along with criminals, the physically deformed, and mentally insane. These 
negative attitudes toward individuals with ID drove the segregation of these individuals into 
institutions away from the rest of society (Scheerenberger, 1983).  
In 1924, one of the field’s leaders, Fernald, delivered a speech that acknowledged that no 
two individuals with ID were exactly alike: “What is good for one may be bad for another…No 
routine procedure will meet the needs of this highly differentiated group” (Fernald, 1924; 
pp.217-218). Thus, during this time the special education classes evolved and began to recognize 
the student with ID as an individual with differing educational needs (Baker, 1937). In 1930, 
President Hoover’s subcommittee on problems involving mental deficiency introduced the first 
Bill of Rights for the Handicapped Child (Scheerenberger, 1983).  
During the 1940s and 1950s the new version of the Standford-Binet was introduced, 
providing a new classification system for the levels of ID or mental retardation: Borderline (IQ 
67-83), Mild (IQ 50-66), Moderate (IQ 33-49), Severe (IQ 16-32), Profound (IQ 16 or below). 
This new terminology was introduced to avoid the negativism associated with the earlier 
classifications. In 1961, the AAMD distributed their revised definition of ID: ‘Mental retardation 
refers to subaverage general intellectual functioning which orginates in the developmental period 
and is associated with impairment in adaptive behavior’ (Herber, 1961). The revised definition 
placed priority on adaptive behavior in the determination of ID. The first measure of adaptive 
behavior, introduced in 1936, was the Vineland Social Maturity Scale (Doll, 1935). The rising 
interest in adaptive behaviors precipitated the development and funding of learning research. 
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This research investigated nearly every behavioral aspect of children, youth, and adults with 
intellectual disabilities (Scheerenberg, 1983). 
The second half of the twentieth century was marked by institutional reform and efforts 
toward deinstitutionalization. The quality of life and physical environment of the institution 
came under scrutiny; the reformist believed the institution’s residents had a right to live in a 
more normal environment. Efforts went to establish standards to guide the development and 
assessment of programs and to petition legislature for funding. By the 1970s the national goal 
was deinstitutionalization. The primary purpose of the institution changed; the institution was 
now considered a transitory placement intended to rehabilitate and prepare individuals for life in 
the community (Scheerenberger, 1983). This community stage in the evolution of service models 
was characterized by several changes, including a decline in the admission of children and the 
number of adults living in institutions. Also, there was the creation of community settings of 
small residential units and the establishment of community-based day programs serving as 
‘sheltered workshops’ (Greenspan, 1999).  
Greenspan (1999) terms the most recent shift in the service model as the supports stage 
of ID services. This service model is centered on the belief that individuals with ID have more 
potential for success than was previously thought. The current view asserts that progress can best 
be attained when support is given in a ‘normal’ work, school and home setting where services 
are tailored to meet the needs of the individual. This movement focuses on the strengths and 
weaknesses of the individual, and thus has changed the concept of ID. As a result, the supports 




Current Definition of Intellectual Disability  
ID, or mental retardation, is characterized by three criterion: 1) sub-average intellectual 
functioning; 2) significant limitations in adaptive skills; and 3) onset before age 18 (American 
Psychological Association, APA, 2000). Intellectual functioning is defined by the intelligence 
quotient (IQ). IQ is obtained with the use of one or more standardized, individually administered 
intelligence tests (i.e., Standford-Binet, Wechsler Intelligence Scales; APA, 2000), which have 
been noted to have an approximate measurement error of five points. To qualify as having sub-
average intellectual functioning, an individual must have an IQ at 70 or below, which is two 
standard deviations below the mean. Though IQ is a defining factor of intellectual functioning, 
there is widespread dissatisfaction with the reliance on measures of intelligence because of their 
co-variation with socioeconomic factors (Flanagan, Genshaft, & Harrison, 1997). Blatt and 
Kaplan (1966) elucidated the problems and pitfalls of relying too heavily on IQ, thus 
highlighting the necessary consideration of adaptive behavior.  
The second criterion, limitations in adaptive functioning, refers to the inability of an 
individual to cope with life demands typical of someone of his age, background, and community 
surroundings (APA, 2000). This criterion requires significant skill impairment in two or more of 
the following areas: communication, self-care, home living, social/interpersonal skills, use of 
community resources, self-direction, functional academic skills, work, leisure, health, and safety 
(APA, 2000). Scales such as the Vineland Adaptive Behavior Scales (VABS) have been 
designed to assess levels of adaptive functioning (Sparrow, Balla, & Cicchetti, 1984). While 
impairments in intellectual functioning are fairly stable past the age of six, adaptive functioning 
skills are likely to improve with training. The VABS has been normalized on the general 
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population, making it possible to derive overall and sub-scale adaptive behavior scores 
(Greenspan, 1999).  
Onset before age 18 is the final criterion for a diagnosis of ID. APA (2000) states that the 
age of onset depends on the etiology and level of intellectual impairment. That is, more severe 
ID tends to be recognized earlier than milder levels of ID. In addition, retardation associated with 
syndromes such as fragile X syndrome is usually diagnosed at birth, whereas retardation with an 
unknown etiology tends to be diagnosed later (Greenspan, 1999).  
There are currently four degrees of ID that reflect the level of intellectual impairment: 
Mild ID (IQ 50-55 to 70); Moderate ID (IQ 35-40 to 50-55); Severe ID (IQ 20-25 to 35-40), and 
Profound ID (IQ below 20-25). The first level, Mild ID, accounts for approximately 85% of all 
individuals with ID (APA, 2000; Greenspan, 1999). These individuals typically develop social 
and communication skills, have minimal sensorimotor impairment, and are often not easily 
distinguished from non-disabled individuals. Individuals with Mild ID usually achieve social and 
vocational skills, but may require supervision, guidance, and assistance during stressful 
situations. 
Moderate ID, the second level of impairment, accounts for approximately 10% of all 
individuals with ID. These individuals usually acquire communication skills during childhood. 
With moderate supervision, they profit from vocational training and attend to their own personal 
care. Generally, individuals with Moderate ID adapt well to life in the community with 
supervision (APA, 2000). 
The third level of impairment, Severe ID, constitutes for 3% to 4% of all persons with ID. 
These individuals typically do not have communicative speech during early childhood, but may 
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learn to talk and gain some simple self-care skills and some pre-academic skills during school 
age. Persons with severe ID usually require supervision in most settings (APA, 2000).  
The final and most severe degree of intellectual impairment is Profound ID. This level of 
impairment accounts for only approximately 1% of all persons with ID. ID in these individuals 
most often stems from an identified neurological condition. These individuals usually have 
considerable impairment in sensorimotor functioning, communication, and self-care skills. 
However, these skill areas may improve with training (APA, 2000).  
Etiology and Prevalence of ID 
 Predisposing factors to ID range widely, and include biological, psychosocial, or a 
combination of factors. Heredity has been identified as one major predisposing cause. Errors of 
metabolism, as in Tay-Sachs disease, single gene abnormalities, and chromosomal aberrations 
are associated with intellectual disabilities. Alterations in early embryonic development due to 
chromosomal changes and prenatal toxins in syndromes, such as Down syndrome and Fetal 
Alcohol Syndrome respectively, can also result in intellectual deficits. Environmental factors 
before, during, and after birth impact the child’s intellect. For example, fetal malnutrition, 
prematurity, hypoxia, viral infections, and trauma are common etiological factors. Moreover, 
nutritional deprivation, lack of social and linguistic stimulation, infections, traumas, and 
poisoning after birth may also account for impairments (APA, 2000; Leonard & Wen, 2002). 
Although many etiological factors have been identified, approximately 30% to 40% of persons 
with ID have no identified etiology (APA, 2000). 
 Prevalence rates of intellectual deficits have approximated 1% (Larson, Lakin, Anderson, 
Kwak, Lee, & Anderson, 2001; Leonard & Wen, 2002). However, rates have varied among 
studies due to differences in major definitions, classification systems, data collection, and 
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sampling techniques (Roeleveld, Zielhuis, & Gabreels, 1997). Leonard and Wen’s (2002) review 
of the literature asserts that the prevalence of ID varies with gender, maternal race, socio-
economic, and educational status. Richardson, Katz, & Koller (1986) found that male children 
have a higher prevalence of ID than females. The gender difference has been often attributed to 
X-linked conditions, such as Fragile X and unidentified X-linked conditions (Leonard & Wen, 
2002). In addition, environmental factors influenced by social class have an impact on the 
prevalence of ID. Studies have consistently found that the prevalence of Mild ID has been 
strongly associated with low economic status and a poor educational background of the mother 
(Decoufle & Boyle, 1995; Drews, Yeargin-Allsopp, Decoufle, & Murphy 1995). Low birth 
weight is a common indicated risk factor that possibly results from maternal smoking and 
maternal urinary tract infections (Leonard & Wen, 2002).  
Dual Diagnosis 
 Individuals with ID are estimated to be three to four times more likely to have a 
psychiatric disorder than those in the general population (APA, 2000; Borthwick-Duffy, 1994). 
Dual Diagnosis, the coexistence of ID and mental illness, is a relatively new concept that has 
developed in the last twenty years. Historically, most professionals thought that individuals with 
ID were incapable of developing psychiatric disorders (Borthwick-Duffy, 1994). Abnormal 
behaviors were most often attributed to the individual’s ID rather than the presence of a mental 
illness (Schroeder, Mulick & Schroeder, 1979). More recently, individuals with intellectual 
deficits were viewed capable of developing mental illness. However, this view holds that a 
mental disorder of a person with ID is qualitatively different than the mental disorder of an 
individual with no intellectual impairment (Szymanski & Grossman, 1984). Current views of 
dual diagnosis are that individuals with ID are likely to have mental disorders similar to those in 
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the general population. Moreover, it is generally recognized these disabled individuals are more 
vulnerable to mental illness than their counterparts in the general population (Borthwick-Duffy, 
1994). 
While most professionals now recognize that individuals with ID are capable and likely 
to suffer from a mental illness, diagnosing the psychiatric disorder in these individuals is not 
easily done. Deficits in communication and adaptive skills often make self-report of symptoms 
impossible, which is frequently the basis of diagnostic interviews and the criteria listed in the 
Diagnostic and Statistical Manual of Mental Disorders 4th ed.-Text Revision (e.g., flight of ideas, 
more talkative than usual, inflated self-esteem, feelings of worthlessness or inappropriate guilt; 
DSM-IV-TR; APA, 2000). Oftentimes these skill deficits are a road block in determining if the 
abnormal behavior is due to psychiatric disorder, brain injury associated with the intellectual 
deficits or environmental factors (Reid, 1983).  
Graham and Rutter (1968) found that while parents and teachers are able to describe their 
child’s abnormal behavior, they are less proficient at interpreting the source of the behavior 
problem. In addition, Costello (1982) asserted that the presence of mental illness in individuals 
with ID often results in an exaggerated interpretation of intellectual deficits. For example, Reiss, 
Levitan, and Szyszko (1982) conducted an experiment presenting a single case to many 
psychologists. The case description was identical except that it varied slightly in the description 
of the individual; psychologists in condition one were given background information indicating 
that the individual was intellectually disabled, psychologists in condition two were told the 
individual was of normal intelligence, and finally, psychologists in condition three were told the 
individual was an alcoholic. Findings from this study and replication studies indicated that the 
presence of ID decreased the importance or salience of abnormal behavior. This phenomenon, 
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commonly called diagnostic overshadowing, is based on the tenet that intellectual deficit is such 
a salient feature of ID that any co-occurring abnormal behavior is attributed to the deficits in 
intelligence. 
Although currently there is a lack of appropriate diagnostic criteria specifically for 
persons with ID, several researchers have developed assessment scales to assess 
psychopathology in this population (Rush, Bowman, Eidman, Toole, & Mortenson, 2004). 
Scales such as the Aberrant Behavior Checklist (ABC; Aman, Singh, Stewart, & Field, 1985), 
the Reiss Screen for Maladaptive Behavior (Reiss, 1988), the Assessment of Dual Diagnosis 
(ADD; Matson, 1997) and the Diagnostic Assessment for the Severely Handicapped-Revised 
(DASH-II, Matson, 1995) are used to aid in the screening and/or diagnosis of psychopathology 
in the intellectually disabled population.  
Etiology of Dual Diagnosis 
 Organic, behavioral, developmental, and sociocultural models have been proposed as 
etiological theories for dual diagnosis (Matson & Sevin, 1994). Organic models of dual diagnosis 
focus on physiological, biochemical, and genetic factors that may predispose individuals to 
mental illness. For example, the high occurrence of individuals with Downs Syndrome 
developing Alzheimer’s dementia is suggestive of an underlying genetic cause of this 
psychopathology (Sovner & Pary, 1993).  
 Behavioral models emphasize the interactions between the individual and the 
environment. These models focus on the principles of classical conditioning, social learning 
theory and operant psychology (Matson & Sevin, 1994). Pavlovian classical conditioning models 
have been discussed in the development of anxiety in the general population and in individuals 
with ID (Ollendick & Ollendick, 1982). Social learning theory suggests that fears and phobias 
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may be the result of an individual observing another’s reaction to an event or object (Matson & 
Sevin, 1994). Operant models, on the other hand, are based on the principles of inadequate 
reinforcement of prosocial behaviors, inappropriate punishment, reinforcements of deviant 
response sets, and altered stimulus-response functions such as decreased learning abilities 
(Matson & Sevin, 1994).  
 Developmental models suggest that development and sequences of cognitive 
development are fixed and universal. Individuals with ID develop at slower rates than the general 
population. Thus, their behavior is indicative of their stage of development. Sternlicht (1979), for 
example, found that patterns of fears of instutionalized individuals with ID were typical of their 
developmental stage.  
 The final model, the sociocultural theory of dual diagnosis, highlights the social 
experience of the individuals and how they may impact psychopathology. Reiss and Benson 
(1984), for example, have pointed out the numerous negative experiences of individuals with ID 
such as restrictive placements and social rejection that may impact their mental health. 
Moreover, Rojahn, and Tasse (1996) asserted that one possible explanation for the increased 
rates of psychopathology in individuals with intellectual deficits is their lack of coping skills. 
Not being able to cope with stressful situations may lead to a higher vulnerability to 
psychopathology and behavior problems. Though there are several promising models for dual 
diagnosis, investigators should continue to study possible etiological factors of psychopathology 
(Matson & Sevin, 1994). 
Prevalence of Dual Diagnosis 
Similar to what was found in the prevalence studies of ID, prevalence rates of dual 
diagnosis within the disabled population are confounded with issues concerning definitions, 
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diagnosis, sampling, and data collection (Borthwick-Duffy, 1994). Identifying dual diagnosis 
requires reliable and valid assessments of both ID and mental illness. Aman’s (1991) review of 
instruments indicated that the psychometric properties of the scale must be considered for both 
the overall psychopathology and the specific diagnosis. For example, the Reiss Screen is based 
on a representative but small standardization sample, which could have implications on the 
confidence in the cut-off scores. Further, sampling techniques complicate the task of estimating 
prevalence. Many investigations dealing with prevalence of dual diagnosis are based on samples 
of institutionalized individuals or service system databases. These samples tend to be skewed 
toward individuals with greater disability who are in need of services, and thus unrepresentative 
of the intellectually disabled population. These issues result in inflated estimates of dual 
diagnosis (Borthwick-Duffy, 1994).  
 Borthwick-Duffy and Eyman (1990) asked the question, “Who are the dually 
diagnosed?” After reviewing demographic, adaptive and maladaptive behavior, and diagnostic 
information for clients receiving state services, the authors concluded that individuals who are 
referred for psychiatric evaluation and consequently dually diagnosed are likely to have higher 
cognitive capabilities. That is, individuals with the cognitive capacity to cause disruptions in 
daily life and lack social skills are more likely to be referred because of their challenging 
behaviors (e.g., aggression, unacceptable social behavior, and resistance). Secondly, individuals 
residing in an institution are more likely to have access to qualified professionals to assess for 
psychopathology, thus increasing the likelihood of dual diagnosis. Finally, diagnostic 
overshadowing often plays a role in the prevalence rate of dual diagnosis across levels of ID. 
That is, individuals with profound intellectual deficits are less likely to be identified as mentally 
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ill because of the severity of their intellectual deficits and the tendency to attribute abnormal 
behavior to low IQ rather than a psychiatric disorder.  
 Findings toward the relationship of dual diagnosis with age, gender, residential setting, 
and intellectual level have been largely inconsistent. Many researchers assert that the prevalence 
of mental illness is highest among individuals with mild intellectual deficits. Individuals with 
mild intellectual deficits are more likely to be aware of their limitations than individuals with 
more severe deficits. That said, Kerker, Owens, Zigler, and Horwitz (2004) hypothesize that 
individuals with mild intellectual deficits may be at a higher risk of reacting to stressful life 
events with an affective disorder. These authors also point out that the differences in prevalence 
estimates may result from the difficulties in diagnosing mental illness in individuals with severe 
intellectual deficits.  
Despite the aforementioned inconsistencies, there is an agreement that certain mental 
illnesses are more prevalent in persons with ID than in the general population. Kerker et al. 
(2004) report that adults with ID are more often diagnosed with anxiety and psychotic disorders 
than individuals without ID. Children with ID are more likely to have an anxiety disorder; 
however, estimates for affective disorders and ADHD are similar to non-disabled children. 
Further, Borthwick-Duffy and Eyman (1990) identified eight behaviors that are associated with 
dual diagnosis: depression, aggression, self-injury, resistive behaviors, temper tantrums, running 
or wandering away, adjustment changes in social relationships, and socially inappropriate 
behavior.  
Bipolar Disorder 
 The focus of the present study is the characteristics of bipolar disorder in individuals with 
ID. An overview of the history, description, prevalence, assessment, and treatment of bipolar 
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disorder in the general population will be reviewed. Then, the focus will shift to bipolar disorder 
in individuals with ID.  
History of Bipolar Disorder 
 Bipolar disorder, previously called manic-depressive disorder, is by no means a new 
illness; it has captured the interest of scholars since the ancient times (Johnson, 2004). Mania and 
melancholia are two of the earliest described diseases. Hippocrates was the first to systematically 
describe mania and melancholia; he included them in his first classification of mental disorders: 
mania, melancholia and paranoia (Angst & Marneros, 2001). However, these classical 
conceptualizations of mania and melancholia were much broader than they are today.  
 Aretaeus of Cappadocia, who was strongly influenced by Hippocrates, was the first to 
conceptualize bipolarity. Though, he did differentiate a biologically and psychologically caused 
melancholia, the later termed ‘reactive depression’. Aretaeus believed mental disorders are of 
biological causes. Most importantly, Aretaeus was the first to link mania and melancholia; he 
viewed them as two different images of the same disease. He asserted that mania and 
melancholia were of the same etiology. Further, he suggested mania was considered a worsening 
of melancholia (Angst & Marneros, 2001).  
 It was not until 1851 that Jean-Pierre Falret first characterized a separate mental disorder 
as a continuous cycle of depression, mania, and free intervals of varying lengths. This change 
from mania to melancholia intermixed with intervals free of symptoms, termed by Falret as folie 
circulaire, was considered to be a disease on its own. The following years were filled with 
debates between Falret and Jules Baillarger on the importance of the interval between 
symptomatic episodes of mania or melancholia; that is, whether the interval between episodes is 
a conceptual aspect of the disease. In 1884, the concept of the disorder had reached general 
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acceptance with publications in Brain and American Journal of Insanity (Angst & Marneros, 
2001).  
As early as 1921, Emil Kraepelin’s description of manic-depressive insanity with its 
variability and patterns of symptoms were similar to descriptions of bipolar disorder in 
diagnostic manuals today such as the Diagnostic and Statistical Manual of Mental Disorders 
(Johnson, 2004). However, it was Carl Wernicke that pointed out the distinction between manic-
depressive illness and recurrent depression or recurrent mania. Later, Wernicke’s colleague, Karl 
Kleist differentiated between unipolar and bipolar affective disorders. Moreover, Kleist 
suggested that monopolar mania is separate from manic-depressive disorders. However, this 
distinction was not recognized by the international psychiatric community for many years (Angst 
& Marneros, 2001).  
In 1966, publications supporting the differentiation between unipolar and bipolar 
disorders brought about the ‘rebirth’ of bipolar disorder (Angst, 1966 as cited in Angst & 
Marneros, 2001; Perris, 1966 as cited in Angst & Marneros, 2001). The findings of these 
publications were similar. One investigation of 326 patients, treated between 1959 and 1963, 
concluded that: 1) genetics and the environment are significant etiological factors of depression; 
2) there is a relationship between female gender and endogenous depression, though, bipolar 
disorders are equally represented in both males and females; 3) manic-depressive illness is 
categorically heterogeneous. Unipolar depression differs significantly from bipolar disorders in 
many characteristics such as genetics, gender, course and premorbid personality; and 4) late-




Current Definition of Bipolar Disorder 
 Although mania was the main characteristic of the classic disease, recent literature 
suggests a spectrum of bipolar disorders including lesser degrees of excitement (Thomas, 2004). 
There are several different types of mania. Pure mania or euphoric mania is the classically 
recognized state of euphoria and grandiosity. A presentation of dysphoric mania, accounting for 
up to 40% of all bipolar episodes, typically includes irritability, crying, hopelessness, and 
suicidal ideation (Akiskal et al., 1998). Hypomania is characterized by a less severe intensity and 
duration of mania, oftentimes not resulting in significant impairment in social or occupational 
functioning (APA, 2000; Thomas, 2004). Further, Johnson (2004) suggests that these symptoms 
of mania can vary a great deal from person to person. 
Currently, there are four major subtypes of this disorder in the Diagnostic and Statistical 
Manual of Mental Disorders, 4th edition –Text Revision (DSM-IV-TR): bipolar I, bipolar II, 
cyclothymia, and bipolar not otherwise specified (NOS). The key feature of bipolar I disorder is 
the presence of a single lifetime manic or mixed episode; depression is not a diagnostic criterion. 
The DSM-IV-TR  (APA, 2000) states that the essential feature of bipolar I disorder is a clinical 
course that is characterized by the occurrence of one or more manic or mixed episodes. A manic 
episode is defined as a distinct period of at least one week, during which mood is abnormally and 
persistently elevated, expansive, or irritable. This mood disturbance must be accompanied by at 
least three additional symptoms including inflated-self esteem or grandiosity, decreased need for 
sleep, pressure of speech, flight of ideas, distractibility, increased involvement in goal-directed 
activities or psychomotor agitation, and excessive involvement in pleasurable activities with a 
high potential for painful consequences. A mixed episode is defined as a period of one week 
during which the criteria are met for both a manic episode and a major depressive episode. Mood 
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disturbances for both a manic and mixed episode must be sufficiently severe to cause marked 
impairment in occupational or usual social functioning, result in hospitalization, or have 
psychotic features (APA, 2000).  
 Bipolar II disorder, on the other hand, is diagnosed on the basis of a single lifetime 
episode of hypomania and at least one episode of major depression. DSM-IV-TR (APA, 2000) 
states that the essential feature of bipolar II disorder is a clinical course that is characterized by 
the occurrence of one or more major depressive episodes accompanied by at least one episode of 
hypomania. A major depressive episode is defined by a period of at least two weeks during 
which there is either depressed mood or the loss of interest or pleasure in nearly all activities. 
The individual must also experience four additional symptoms including changes in appetite or 
weight, sleep, and psychomotor activity; decreased energy; feelings of worthlessness or guilt; 
difficulty thinking, concentrating, or making decisions; and recurrent thoughts of death or 
suicidal ideation, plans, or attempts.  
A hypomanic episode is defined by a distinct period in which there is an abnormally and 
persistently elevated, expansive, or irritable mood that lasts at least four days. This period must 
also be accompanied by at least three additional symptoms including inflated self-esteem or 
grandiosity (non-delusional), decreased need for sleep, pressure of speech, flight of ideas, 
distractibility, increased involvement in goal-directed activities or psychomotor agitation, and 
excessive involvement in pleasurable activities that have high potential for painful consequences. 
There must be a clear change in functioning that is observable by others and is not characteristic 
of the individual’s usual functioning. Unlike the criteria for a manic episode, a hypomanic 
episode is not severe enough to cause marked impairment in social or occupational functioning, 
or to require hospitalization, in addition, there are no psychotic features (APA, 2000). Johnson 
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(2004) points out that individuals who have lifetime episodes of hypomania but do not 
experience depression do not qualify for any diagnosis, as these periods of hypomania may not 
result in severe impairment in functioning. 
Cyclothymic disorder, in comparison to bipolar I and bipolar II, is a milder form of mood 
disorder. The DSM-IV-TR describes cyclothymia as a chronic, fluctuating mood disturbance 
involving numerous periods of hypomanic symptoms and numerous periods of depressive 
symptoms. However, the hypomanic and depressive symptoms are of insufficient number, 
severity, pervasiveness, or duration to meet the criteria for a mania or major depressive episode. 
It is not necessary for any of the episodes to meet criteria for a hypomanic episode. These 
fluctuations of mood must last for at least two years in which there is no period of more than two 
months that the individual is without hypomanic or depressive symptoms. It is estimated that 
individuals with cyclothymia have a 15%-50% risk of subsequently developing bipolar I or 
bipolar II disorder (APA, 2000).  
Bipolar Not Otherwise Specified (NOS) includes bipolar features that do not meet criteria 
for any specific bipolar disorder. Some examples of this situation cited in the DSM-IV-TR 
include rapid variation between manic and depression symptoms that do not meet criteria for 
duration; recurrent hypomanic episodes without intercurrent depressive symptoms; manic or 
mixed episode superimposed on delusional disorder, residual schizophrenia, or psychotic 
disorder; and hypomanic episodes that are too infrequent to qualify for a diagnosis of 
cyclothymic disorder. Finally, situations in which the clinician has concluded that a bipolar 
disorder is appropriate (but unable to determine whether it is primary), due to a general medical 
condition or substance induced would warrant a diagnosis of bipolar NOS . (APA, 2000).  
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Recently, new forms of bipolar disorder have been suggested. These include bipolar II-
1/2 (depression superimposed on cyclothymic temperament), bipolar III or “pseudo-unipolar” 
(mania or hypomania associated with the prescription of antidepressants for depressive 
disorders), and bipolar IV (depression arising from a hyperthymic temperament). However, these 
new forms or subtypes of bipolar disorder have yet to be formally accepted (Thomas, 2004).  
Characteristics 
 Bipolar disorder is typically a lifelong illness characterized with manic or hypomanic 
episodes that may or may not be accompanied with depression. Illness onset usually occurs 
before the age of 25. However, due to the episodic feature of the disorder, an accurate diagnosis 
is often not obtained immediately. For example, Benazzi and Akiskal (2003) reported that up to 
50% of individuals with major depressive episodes have bipolar II disorder. This suggests that a 
systematic search for hypomanic episodes would result in a re-diagnosis of ‘unipolar’ depressed 
persons as bipolar II disordered. Bipolar disorder is often misdiagnosed as unipolar depression or 
schizophrenia, while milder forms of the disorder such as cyclothymia are likely to be 
misdiagnosed as personality disorders (Akiskal, Hantouche, & Allilaire, 2003; Daniels, Kirkby, 
Mitchell, Hay, & Bowling, 2003). Moreover, the range of clinical presentation, psychiatric co-
morbidity, mixed states, and rapid cycling further complicate diagnosis (Thomas, 2004).  
Accurate diagnosis and treatment is critical as this illness has a high mortality rate. 
Studies by Lish, Dime-Meenan, Whybrow, Price and Hirschfeld (1994) and Hantouch, Azorin, 
Chatenet-Duchene, Lancrenon, Allilaire and Akiskal (2003, as cited in Thomas, 2004) assert that 
treatment is oftentimes not started until up to 10 years after the onset of the illness. Thomas 
(2004) found that reported lifetime risk for suicide attempts range from 25% to 50%, and suicide 
attempts resulting in death occur in 10% to 15% of individuals who are not adequately treated. 
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Catatonic features, cognitive impairment (e.g., impairment in verbal memory; Quraishi & 
Frangou, 2002), conduct disorders, and psychoactive substance abuse are also associated features 
of this disorder (Thomas, 2004).  
Comorbid psychopathology among individuals with bipolar disorder appears to be the 
rule rather than the exception. Estimates of comorbidity show that more than two-thirds of 
individuals with bipolar disorder have another psychiatric disorder (Thomas, 2004). Most 
common co-existing psychiatric disorders are panic disorder, generalized anxiety disorder, 
obsessive-compulsive disorder, bulimia nervosa and substance abuse (Angst, 1998; Freeman, 
Freeman, McElroy, 2002; Perugi et al., 1998). Goodwin and Hoven (2002) in their community-
based household sample from a National Comorbidity Survey found that panic attacks are not 
uncommon among individuals with bipolar disorder in the general population. Further, the 
presence of panic attacks in these individuals is associated with significantly elevated rates of 
comorbid psychopathology (i.e., more likely to meet criteria for comorbid agoraphobia, simple 
phobia, generalized anxiety disorder, and substance abuse). 
Etiology 
 Current literature suggests that there is a familial nature of bipolar disorder; that is, 1) 
mood disorders occur at a higher rate in the families of bipolar patients, and 2) a variety of mood 
syndromes and symptoms that differ both qualitatively and quantitatively from bipolar disorder 
occurs in the families of bipolar patients (Kelsoe, 2003). Kelsoe’s (2003) review of family 
studies conducted over the past decades indicated that approximately 7% of people with bipolar 
disorder have first degree relatives that also have bipolar disorder (compared to 1% general 
population prevalence) and approximately 10% of people with bipolar disorder have first degree 
relatives that have unipolar depression (compared to 5% general population prevalence). This 
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suggests a sevenfold increased risk of having bipolar disorder and a twofold increased risk of 
having unipolar depression if there is someone with bipolar disorder in the family. Twin studies 
also lend support to the genetic basis of bipolar disorder. A meta-analysis of the twin studies 
found that approximately 70% of monozygotic pairs are concordant for the illness, while only 
30% of dizygotic pairs are concordant for the illness (Kelsoe, 2003). Adoption studies also found 
an elevated rate of illness in biological parents and only a population rate in the adoptive parents 
(Mendlewicz & Rainer, 1977; Wender et al. 1986). Kelsoe’s (2003) conclusions from his review 
of several studies regarding the genetic basis of bipolar disorder are that 1) genes explain only a 
portion of the etiology, with environmental factors likely playing a substantial role; and 2) the 
trait displays variable expressivity, meaning a variety of clinically related presentations can 
result from the same genes. This last conclusion lends support to the characterization of bipolar 
as a spectrum of disorders.  
 As biological variables do not fully explain the individual differences in severity or 
changes in presentation overtime, the current literature highlights several psychosocial variables 
that may have an influence on the course of the disorder (Johnson & Meyer, 2004). Expressed 
emotion, defined as emotionally intrusive or hostile comments from family members toward 
individuals with the disorder, was one of the first environmental variables identified as impacting 
the course of the disorder. Although expressed emotion has been shown to be relevant to other 
disorders such as schizophrenia, the effect size appears to be much larger for individuals with 
mood disorders than those with schizophrenia (Butzlaff & Hooley, 1998). This confirms the 
critical importance of psychoeducation for the family members in the treatment of individuals 
with bipolar disorder.  
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 Social support is another factor that has been suggested. Romans and McPherson (1992) 
found that individuals with bipolar disorder experience less social support than those without 
mental disorders. Further, they found that social support is lower for people with a history of 
more manic episodes. Johnson, Meyer, Winett and Small (2000) have suggested that an absence 
of emotional support has been related to poorer course of the disorder, including more frequent 
relapse and less successful lithium treatment. 
 Presence of negative life events has also been investigated as an impacting factor. As the 
methodology and the potential confounding variables (i.e., poor coping skills) vary across 
studies, it is difficult to quantify the impact of these events. Johnson and Meyer (2004) assert that 
the literature has consistently supported the relationship between life events and increases in 
symptoms. Further, these findings seem to hold even after excluding events that result from 
symptoms or deficits in coping. The authors suggest that the best predictors of course within the 
life-event domain appear to be major negative life events that are associated with loss (i.e., death 
of a family member).  
 Johnson and Meyer (2004) assert that individuals who are able to maintain non-critical 
family relationships, maintain strong social support, and have lower rates of negative life events 
are likely to have fewer symptoms of bipolar disorder over time. Also, personality traits, such as 
neuroticism, have also received some attention as mediating factors in the course of the disorder. 
However, as methodological approaches have varied widely and studies oftentimes do not 
control for syndromal symptoms, it is difficult to ascertain the impact of personality factors on 
the course of the disorder.  
 The literature indicates that psychosocial variables do have an important role in the 
course of bipolar disorder. Further, these variables have been found to exacerbate symptoms of 
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depression and mania in the disorder. Symptoms of depression have been associated with 
negative life events, low social support and poor self esteem; whereas sleep deprivation, and 
behavioral activation have been associated with mania (Johnson & Meyer, 2004). Colombo, 
Benedetti, Barbini, Campori and Smeraldi (1999) reported that as many as 10% of patients with 
bipolar disorder developed hypomanic or manic symptoms after induced sleep deprivation. 
Moreover, Wehr, Turner, Shimada, Lowe, Barker, and Leibenluft (1998) published case studies 
that suggest that increasing sleep regulation in individuals with bipolar disorder may have an 
impact on symptom reduction. Johnson and Meyer (2004) indicate that recent research suggests 
that behavioral activation system sensitivity tends to be higher among individual with bipolar 
disorder than comparison samples. Further, the research suggests that higher behavioral 
activation system sensitivity predicts a greater risk of mania over time. It has been suggested that 
bipolar disorder may reflect dysregulation of the ventral tegmental dopamine-secreting neurons, 
which is the hypothesized central tract involved in the behavioral activation system (Depue & 
Zald, 1993; Hestenes, 1992).  
Prevalence 
 Classic prevalence rates of bipolar have estimated 0.8% to 1.7% for full mania and 
appear comparable across cultures (Angst, 1998; Johnson, 2004; Thomas, 2004). Low lifetime 
prevalence rates of hypomania have been reported to range between 0.5% and 1.9% (Angst, 
1998). Consequently, with the recent shift toward conceptualizing bipolar as a spectrum of 
disorders (including hypomania, recurrent brief hypomania, sporadic brief hypomania, and 
cyclothymia), current literature suggests that bipolar affects at least 5% of the general population 
(Akiskal, Bourgeois, Angst, Post, Moller & Hirschfeld, 2000; Angst, Gamma, Benazzi, Ajdacic, 
Eich & Rossler, 2003; Judd & Akiskal, 2003). Of course, as mentioned earlier, misdiagnosis of 
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bipolar disorder is common (Daniels, Kirkby, Mitchell, Hay & Bowling, 2003). Therefore, 
caution is warranted when making conclusions based on these reported prevalence rates.  
Assessment 
 The most common methods used to diagnose bipolar disorder in the general population 
cited in the research literature are structured interviews such as the Structured Clinical Interview 
for DSM (SCID) based on the DSM, or prior to 1980, the Schedule for Affective Disorders and 
Schizophrenia (SADS based on Research Diagnostic Criteria (RDC; Altman, 2004; Matson, 
González, Dixon, Cooper & Matson, 2004). Matson et al. (2004) found that 124 out of 164 
(75%) published studies in the bipolar literature in the past 20 years used DSM criteria for 
diagnosis; oftentimes DSM criteria was used in conjunction with a structured interview such as 
the SCID.  
 Schedule for Affective Disorders and Schizophrenia (SADS). Prior to the advent of 
DSM-III in 1980, the RDC was the primary instrument for diagnosing psychiatric disorders in 
the United States. Information required for making diagnosis based on RDC was gathered 
through a structured interview using the SADS. This interview assessment contains interview 
questions and guidelines that allow clinicians to obtain information about the presence and 
severity of symptoms in a standardized manner. Some training is required for reliable 
administration. There are multiple versions of the SADS; the SADS change version is used to 
assess outcome in treatment studies, while the lifetime version is used for diagnosing past 
episodes (Altman, 2004; Endicott & Spitzer, 1978).  
 Structured Clinical Interview for DSM (SCID). With the shift to the use of the DSM-
III, the SCID was developed to provide clinicians a standardized diagnostic instrument for 
deriving DSM-III diagnoses. The SCID’s structured format is similar to that of the SADS’s, but 
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is intended for diagnosis only; the SCID does not assess the severity of symptoms. It has been 
modified with revisions of the DSM. The SCID does require some degree of clinical training and 
practice for reliable administration. It is available in different formats such as versions for Axis I 
disorders (SCID-I), personality disorders (SCID-PD), and family members or non-patients 
(SCID-NP; Altman, 2004; Spitzer, Williams, Gibbon, & First, 1992). 
A variety of rating scales are available to assess the severity of bipolar disorder; these 
include observer-rated, clinician-rated, and global mania scales. Newer rating scales have 
evolved from the early nurse rating scales of the 1970s (i.e., Manic State Rating Scale, MSRS; 
Beigel, Murphy & Bunney, 1971). Improvement in rating scales over the past years have focused 
on clear operational definitions of symptoms; well-defined anchor points for assessing severity; 
more relevant item content (consistent with DSM criteria); guidelines for administration, scoring 
and interpretation; and reporting of reliability and discriminant and concurrent validity 
coefficients.  
Manic State Rating Scale (MSRS). The MSRS was the first observer-rated mania scale; 
it was designed for use by nursing staff after long-term observation (i.e., 6 to 8 hour shifts) in the 
hospital ward. It contains 26 items assessing both the frequency and intensity of various signs 
and symptoms. Limitations of this scale include the long observation period, the specialized 
training required, inclusion of items not specific to mania (i.e., suspiciousness, depressed affect), 
and the absence of one key symptom (i.e., sleep disturbance; Altman, 2004; Beigel, Murphy & 
Bunney, 1971).  
Manchester Nurse Rating Scale for Mania (MNRS-M). This observer-rating scale, an 
improved version of the MSRS, is suitable for the daily monitoring of affective states. It contains 
nine items rated from 0 (not present) to 3 (usually present). It does not require specialized 
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training to administer reliably. Authors report good inter-rater reliability and concurrent validity 
with global ratings of mania, r = .95 and r = .65 respectively. It is a more compact and easier 
scale to administer when compared to the MSRS; however, it does not include a measure of 
sleep disturbance (Altman, 2004; Brierley, Szabadi, Rix & Bradshaw, 1988).  
Bech-Rafaelson Mania Scale (BRMS). The BRMS, a clinician rating scale, consists of 
11 items, each is rated from 0 (normal) to 4 (extreme). Four of the 11 items are devoted to 
activity level alone (e.g., motor activity, verbal, sexual, work and interests), though there is no 
item to assess distractibility. The authors report high interrrater reliability (r = .80 - .95). Smolka 
and Stieglitz (1999) report that discriminant validity of the BRMS is high, r = .80. Further, Bech 
(2002) documents the effectiveness of the BRMS as an outcome measure in clinical trials 
(Altman, 2004; Bech, Rafaelson, Kramp & Bolwig, 1978). 
Young Mania Rating Scale (YMRS). The most widely used clinician-administered 
rating scale for mania is the YMRS (Young, Biggs, Ziegler, & Meyer, 1978). It contains 11 
items, four of which are scored 0-4 and the remaining seven are scored from 0-8, based on 
severity. The YMRS is designed as a 15 to 30 minute interview administered by trained 
clinicians. It has been used extensively to assess treatment response in clinical trial studies. It is 
considered to be the gold standard to which scale developers evaluate concurrent validity with 
newer scales. The authors report good inter-rater reliability for items (r = .66 - .92) and total 
scores (r = .93), and good concurrent validity (r = .71) with the MSRS (Beigel, Murphy, & 
Bunney, 1971) and global ratings (r = .88). Limitations include the fact that there is no guideline 
to ensure standardized administration, no report of discriminant validity or test-retest reliability 
(Altman, 2004). One criticism raised by Altman (2004) is that the YMRS combines symptoms of 
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mania with psychotic symptoms to yield a total score; he suggests that this is troublesome as 
these symptoms may respond differently to treatment. 
Clinical Global Impressions Bipolar Scale (CGI; Guy, 1976). The CGI is one of the 
earliest general global rating questionnaires used for psychopharmacology treatment studies. Its 
revised version, the Clinical Global Impressions Bipolar scale (CGI-BP; Spearing, Post, 
Leverich, Brandt, & Nolen, 1997), contains guidelines clarifying concepts and explanations and 
rules for ratings. This version includes separate scores for depression and mania; symmetrical 
scores on a seven-point scale; categories to rate symptoms on admission, during an acute 
episode, and during prophylactic periods; and a section to rate medication side effects. Inter-rater 
reliabilities for severity (r = .91), change from last assessment (r = .86), and change from worst 
phase of illness (r = .76) have been reported (Altman, 2004).  
Mania-Depression Scale (MDS; Mazmanian et al., 1994). The MDS is a global 
clinician-rated severity scale with scores ranging from –5 (depressive stupor) to 0 (euthymic) to 
+5 (manic delirium). Each severity point has defining descriptive behaviors. It is easy to 
administer, allows for the assessment of both manic and depressive symptoms, and is sensitive to 
daily variation and treatment effects. Inter-rater reliability is good (r = .84) and concurrent 
validity is reported as r = .59 with the self-rating Beck Depression Inventory and r = .71 with a 
visual analogue mood scale (Altman, 2004).  
 Matson et al.’s (2004) review of treatment studies noted that investigators used various 
methods to assess bipolar disorder in their studies. A frequency count of the use of these 
assessment scales indicated that the SCID, Hamilton Depression Rating Scale (HAM-D), SADS, 
and YMRS were the assessment scales other than DSM most often used as inclusion criteria. 
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Further, HAM-D, CGI, and YMRS were most often used to assess the efficacy of the treatment 
in question.  
Treatment 
Practice guidelines for the treatment of patients with bipolar disorder state that the 
specific goals of treatment are “establishing and maintaining a therapeutic alliance, monitoring 
the patient’s psychiatric status, providing education regarding bipolar disorder, enhancing 
treatment compliance, promoting regular patterns of activity and of sleep, anticipating stressors, 
identifying new episodes early, and minimizing functional impairments” (American Psychiatric 
Association, 2002, p.4). Kasper and Attarbaschi (2004) suggest that treatment for mania, 
specifically, aims to rapidly control the irritability, agitation, impulsivity, aggression, and 
psychotic symptoms that are often symptomatic of mania. There are several treatment 
approaches available that seek to help manic individuals to regain and maintain pre-morbid 
functioning. Medication is the most widely used treatment of bipolar disorder; however, it is 
sometimes used in conjunction with other psychoeducational treatment methods such as 
cognitive-behavioral therapy, interpersonal-social rhythm therapy, or family therapy (Michalack, 
Yatham, Lam, 2004). Alternatively, electroconvulsive therapy (ECT) is also considered to be a 
treatment option (American Psychiatric Association, 2002).  
Pharmacological treatment of bipolar disorder is common. The most often used types of 
medications are lithium, anticonvulsants, atypical antipsychotics, and antidepressants. Currently, 
there are only five medications approved by the United States Food and Drug Administration 
(FDA) for the treatment of bipolar disorder: lithium, chlorpromazine, divalproex, olanzapine, 
and lamotrigine. Presently, there is very little evidence to link any pharmacological activity to 
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antimanic or antidepressant effects (Goldberg, 2004). The evidence of the antimanic efficacy of 
these medications is summarized below.  
Lithium. Lithium is the most extensively studied agent for relapse prevention in bipolar 
disorder (Goldberg, 2004). It remains a cornerstone drug for both short and long-term treatment 
of bipolar disorder. Research by Tondo and Baldessarini (2000) suggest that lithium may be 
effective in reducing suicide risk. Despite its common use and favorable aspects, lithium is 
commonly associated with the following side effects: tremor, thirst, urinary frequency, 
constipation, blurry vision, sedation, and acne (Goldberg, 2004).  
 Anticonvulsants. Anticonvulsants commonly studied for the treatment of bipolar are 
divalproex, carbamazepine, oxcarbazepine, lamotrigine, gabpentin, and topiramate. Although 
many anticonvulsants are prescribed to treat bipolar disorder, only divalproex and carbamazepine 
have found to be effective in placebo-controlled studies (Pope, McElroy, Keck, & Hudson, 1991; 
Post, Rubinow, & Ballenger, 1986). Lamotrogine is the only anticonvulsant effective as an 
antidepressant (Calabrese, Bowden, Sachs, Ascher, Monaghan, & Rudd, 1999). Furthermore, the 
side effects of anticonvulsant medications vary widely (e.g., dizziness, sedation, paresthesias, 
gait unsteadiness; Goldberg, 2004).  
 Antipsychotics. Atypical antipsychotics commonly prescribed to treat bipolar include: 
olanzapine, ziprasidone, risperidone, quetiapine, clozapine and aripiprazole. Olanzapine, 
however, is presently the only atypical antipsychotic recognized by the FDA for the treatment of 
acute mania. Its efficacy over acute mania (Tohen et al., 1999; Tohen et al. 2000) and mixed 
states (Tohen et al., 2000) has been demonstrated. Controlled studies support the 
monotherapeutic use of olanzapine, risperidone, or aripiprazole in acute mania, while olanzapine, 
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risperidone, quetiapine and clozapine have support for adjunctive use (Goldberg, 2004). Further, 
placebo-controlled research is needed to investigate the efficacy of these medications.  
 Antidepressants. A central concern over the use of antidepressants for treatment of 
bipolar depression is its potential to induce mania or accelerate cycle frequency in about 20-40% 
of individuals (Altshuler et al., 1995; Goldberg & Whiteside, 2002). Altshuler et al. (2001) 
suggest that there are no controlled data to support the notion that long-term antidepressants help 
to avoid depression relapse any better than mood stabilizers. Current American Psychiatric 
Association Practice Guidelines advise against using antidepressants alone in patients with 
bipolar I disorder (American Psychiatric Association, 2002); however, Goldberg (2004) suggests 
that antidepressants may prove to be useful when other pharmacotherapies yeild less than 
optimal results.  
Though pharmacological agents are the cornerstone of treatment, adherence to treatment 
and the presence side effects are oftentimes problematic (Goldberg, 2004). Thus, other 
treatments such as cognitive-behavioral therapy, interpersonal social rhythm therapy, and family 
therapy are often used in conjunction with medication. 
Cognitive-behavioral therapy. Cognitive-behavioral therapy is most often used in 
combination with pharmacotherapy (Leahy, 2004). The medication is used to help stabilize or 
reduce fluctuations in mood, while cognitive therapy aids the individual in managing his moods 
when they occur (Leahy, 2004). Leahy (2004) suggests that the content of cognitive schemas 
differ with mood. As mood changes, these automatic thoughts (e.g., “I’ll get rejected”; “I’ll 
impress everyone”) and maladaptive assumptions (e.g., “ I should be successful at everything”) 
support the individual’s current mood state (depression or mania). Leahy (2004) describes 
cognitive-behavioral therapy as a process of evaluating and learning from past episodes, 
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conducting a cost-benefit analysis of the situation, and finally introducing rational responses 
(e.g., “No one is successful at everything”) to these automatic thoughts and maladaptive 
assumptions.  
Cognitive-behavioral therapy usually focuses on six targets for treatment: 1) medication 
adherence, 2) early detection and intervention, 3) stress and lifestyle management, 4) treatment 
of comorbid conditions, and 5) treatment of bipolar depression (Michalak, Yatham, & Lam, 
2004; Otto, Reilly-Harrington, & Sachs, 2003). Several controlled studies have indicated that 
cognitive-behavioral therapy can positively influence the course of bipolar disorder in aspects 
such as medication compliance (Cochran, 1984); significantly fewer manic, hypomanic and 
depressed episodes (Lam et al., 2000); and the reduction in the number of episodes and 
increasing euthymic periods compared to those in a medication-alone condition (Hirshfeld et al., 
1998).  
Interpersonal and social rhythm therapy (IPSRT). IPSRT is based on the following 
assumptions: 1) instability is the fundamental dysfunction in bipolar disorder; 2) there is a 
relationship between psychosocial stressors and changes in biological rhythms (for example, our 
circadian rhythm is set by zeitgebers such as light, timing of work or meal, etc; Aschoff, 1981); 
and 3) life events that disrupt our social routines are significantly associated with the onset of 
mood fluctuations (Malkoff-Schwartz et al., 2000). Individuals that are vulnerable to disruptions 
may become manic or depressed in response to changes in the regularity of daily routines or 
social rhythms (Frank & Swartz, 2004). IPSRT focuses on helping patients optimize the 
regularity of daily routine, resolve social and interpersonal problems, and understand the illness 
through psychoeducation, social rhythm therapy and interpersonal psychotherapy. Rucci et al. 
(2002) have found that IPSRT is associated with low rates of episode recurrence, increased 
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stability of mood between episodes, and significant reductions in suicidal behavior. One major 
limitation in IPSRT is the challenge of motivating the individual to participate in the therapy and 
make changes in his daily routine. During mood episodes, non-adherence to pharmacological and 
social rhythm treatment may be a major problem (Frank & Swartz, 2004).  
Family therapy. As previously mentioned, the course of bipolar illness over time is 
strongly influenced by stressful life events (Miklowitz, 2004). Miklowitz, Goldstein, 
Nuechterlein, Snyder and Mintz (1988) found that individuals with bipolar disorder who are 
associated with family or marital environments characterized by high expressed emotion (e.g., 
highly critical, hostile, or overprotective attitudes) have more frequent relapse than individuals 
with relationships characterized by low expressed emotion. Family-focused treatment (FFT) 
assumes that increasing the efficiency and emotional tone of the family’s communications and 
problem solving strategies, and encouraging greater tolerability and acceptance of the illness, 
will result in a more stable mood over time (Miklowitz, 2004). Just as family therapy has 
received support in the treatment of other illnesses (i.e., schizophrenia), FFT has received 
empirical support in one open trial (Miklowitz & Goldstein, 1990) and two randomized trials 
(Rea, Tompson, Miklowitz, Goldstein, Hwang, & Mintz, 2003; Simoneau, Miklowitz, Richards, 
Saleem, & George, 1999). The results of these studies suggest that adding FFT to 
pharmacological treatment increases long-term mood stability among individuals with bipolar 
disorder by encouraging medication compliance and enhancing the use of positive 
communication in family relationships (Miklowitz, 2004). 
Electroconvulsive therapy(ECT). Electroconvulsive Therapy is a procedure used in 
treating individuals with severe depression, acute mania, and certain schizophrenic syndromes. 
Oftentimes ECT is used with suicidal patients who cannot wait for pharmacological agents to 
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take effect. This treatment involves a brief application of an electric stimulus that is used to 
produce a generalized seizure. However, it remains unknown how or why this treatment works 
(National Mental Health Association, 2004). Controlled studies have demonstrated its efficacy in 
acute mania and bipolar depression (American Psychiatric Association, 2002). These studies 
indicate that individuals treated with ECT have superior clinical outcomes than individuals on 
medication alone (Sikdar, Kulhara, Avasthi, & Singh, 1994; Small et al., 1988; Mukherjee, 
Sackeim, & Schnur, 1994; Zornberg & Pope, 1993). Although, there are several studies 
indicating the treatment’s efficacy, ECT remains a controversial treatment option due concerns 
over side effects such as memory loss and confusion (National Mental Health Association, 
2004). 
Bipolar Disorder and Intellectual Disability 
Until recently, the majority of research on bipolar disorder in individuals with ID has 
comprised of studies that examine either descriptive case reports, prevalence of behavioral 
features associated with mood states (e.g., SIB, aggression), and/or the efficacy of 
pharmacological treatments (Aman, Collier-Crespin, & Lindsay, 2000; Berney & Jones, 1988; 
Hellings, 1999; Lowry & Sovner, 1992; Vanstraelen & Tyrer, 1999). However, more studies are 
beginning to focus on psychopathology in people with ID and mania. Cain et al. (2003) reported 
a range of challenging behaviors and functional impairments had been associated with mania in 
individuals with ID. For example, Cain et al. (2003) in a retrospective chart review reported that 
intellectually disabled individuals diagnosed with bipolar disorder were more likely to show 
more mood symptoms, such as irritability, elevated mood, and euphoric mood than individuals 
diagnosed with non-psychotic depression, major depression (with psychosis), or schizophrenia. 
Further, persons with bipolar and ID were also reported to be more likely to exhibit non-mood 
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symptoms, such as increased self-esteem, disturbed speech, increased energy, decreased sleep, 
distractibility, and increased engaging in pleasurable activity. In one retrospective case series, 
King (2000) contrasted the phenomenology, outcome, treatment response, and clinical 
characteristics of individuals with rapid and non-rapid cycling and found that those who cycle 
rapidly have a poorer outcome than those who do not. Another study by Wieseler, Campbell, and 
Sonis (1988) reports a case study in which a rating scale, derived from two mania-rating scales 
used in the general population (i.e., Young Mania Rating Scale and Manic State Rating Scale), 
was used to track the rapid cyclic pattern of an intellectually disabled resident with bipolar 
disorder and found periods of behavioral fluctuations in symptoms associated with bipolar 
disorder (i.e., activity/inactivity).  
Prevalence 
 Estimates of individuals being dually diagnosed with bipolar disorder and ID have ranged 
from 0.9% to 4.8% of the intellectually disabled population (Reid, 1972; Ruedrich, 1993a). 
These estimates vary, in part, due to the difficulties in diagnosing bipolar disorder in this 
population. An evaluation of rates of psychopathology in persons with severe and profound ID 
by Kirkpatrick-Sanchez, Williams, Matson, Anderson, and Gardner (1996) indicate that bipolar 
disorder was more often identified in individuals with severe ID in comparison to those with 
profound ID (no cases were identified). Further, Pary, Strauss, and White (1996) in their 
population survey of bipolar disorder in persons with ID found no individuals who had bipolar 
disorder and Down Syndrome. This finding is consistent with other studies, which suggest that 
the prevalence of bipolar disorder is much lower in those with Down Syndrome in comparison 
with individuals with other developmental disabilities. Perhaps this is due to a disturbance in 
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genetics leading to a predisposition to depression and a relative protection from mania (Cooper 
& Collacott, 1993; Craddock & Owen, 1994).  
Assessment  
Cain et al. (2003) suggest that the use of DSM-IV criteria can be useful in the diagnosis 
of bipolar disorder in intellectually disabled persons. However, diagnosing bipolar disorder in 
this population remains challenging because of difficulties in communication, atypical 
presentation, and lack of clear diagnostic criteria (Arumainayagam & Kumar, 1990). Individuals 
with severe intellectual deficits are oftentimes non-verbal, thus the use of methods that rely on 
self-report of feelings is not possible. Hasan and Mooney (1979) indicate that misdiagnosis may 
be more common in this population due to the under-reporting of depressive and manic 
symptoms by their caregivers. Evans, Byerly, and Greer (1995) raise the point that affective 
symptoms may be difficult to distinguish from those related to developmental disabilities. 
Further, it has been suggested that the appearance or presentation of bipolar disorder in this 
population may be distinctly different from the general population (Ruedrich, 1993a). That is, 
mood disorders in the intellectually disabled population are more often atypical, chronic, or rapid 
cycling (Sovner, 1989).  
Ruedrich (1993a) presented three major approaches to assessing bipolar disorder in 
individuals with ID: 1) direct application of current diagnostic systems (i.e., DSM, International 
Classification of Diseases, ICD); 2) an extrapolation and/or minor revisions of current diagnostic 
schemes for application to person with ID (i.e., behavioral equivalents); and 3) development of 
derived diagnostic systems for specific application to persons with ID (i.e., DASH-II). Current 
literature states that clinicians should focus on core DSM or ICD symptoms when diagnosing 
bipolar disorder in individuals with intellectual deficits. In cases when a patient is non-verbal or 
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minimally verbal, it is suggested that attention be focused on the use of observable signs and 
validated psychiatric measures documented by knowledgeable caregivers and the clinician 
(Hellings, 1999; Lowry & Sovner, 1992; Sturmey, Laud, Cooper, & Matson, 2004).  
Treatment  
 Pharmacotherapy. A review of pharmacotherapy of bipolar disorder persons with ID by 
Aman, Collier-Crespin, and Lindsay (2000) indicates that the main pharmacologic treatment in 
this population is lithium alone or in combination with carbamazapine or valproic acid. Several 
case studies describing individuals with ID and bipolar disorder suggest that lithium was 
effective in the management and prevention of manic episodes (Arumainayagam & Kumar, 
1990; Kadambari, 1986; Ruedrich, 1993b). A double-blind long-term trial of lithium indicated 
that treatment with lithium resulted in fewer weeks of illness (Naylor, Donald, LePoidevin, & 
Reid, 1974). Although the majority of the reports are from uncontrolled treatment studies and 
case reports, they consistently suggest that treatment with lithium resulted in improvement in 
symptoms (i.e., remissions of symptoms, Rivinus & Harmatz, 1979; lithium alone or with 
carbamazepine resulted in partial or complete improvement, Glue, 1989). Pary (1991) noted that 
10 out of 15 (67%) individuals with ID had side effects of lithium such as tremor, GI irritation, 
rash, sedation, thirst, and polyuria leading to the discontinuation of their medication.  
 Other pharmacotherapies, such as carbamazepine and valproic acid, also have support as 
effective treatments. Sovner’s (1991) comprehensive review on the use of anticonvulsant agents 
in developmentally disabled individuals concluded that carbamazepine and valproic acid may be 
considered a primary therapy choice with individuals with ID due to lithium’s unreliable 
response and side effects. In this article, Sovner concluded that carbamazepine is useful alone or 
in combination with lithium with atypical or rapid-cycling forms of bipolar. Ruedrich, Swales, 
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Fossaeeca, Toliver, and Rutkowski (1999) report a retrospective chart review of 28 individuals 
on divalproex treatment (valproic acid) with ID that showed significant scale improvement on 
the CGI. Similarly, Buzan, Dubovsky, Firestone, and Pozzo (1998) review data from 10 
individuals treated with clozapine; nine of the 10 patients had improved ratings on the CGI. The 
authors concluded that clozapine was well tolerated and efficacious for psychosis and mania in 
individuals with ID. Controlled studies are needed to further investigate the efficacy of 
pharmacological agents in the treatment of bipolar in individuals with ID.  
  Electroconvulsive therapy. Though pharmacological treatments are the most common 
forms of treatment for bipolar disorder, Aziz, Maixner, DeQuardo, Aldridge, and Tandon (2001) 
suggest that individuals with ID tend to be sensitive to medications and vulnerable to developing 
pronounced side effects. Thus, these authors suggest that electroconvulsive therapy (ECT) may 
be the treatment of choice. Aziz et al. (2001) presented two cases in which previous treatment 
with anti-psychotics and lorazepam yielded no response, while, use of ECT resulted in marked 
improvement in symptoms. Kessler (2004) describes four patients with ID and affective 
disorders (rapid cycling bipolar disorder; bipolar disorder, manic phase; major depression with 
psychotic features; and schizoaffective disorder) who had not responded to prior 
pharmacological treatment. All four patients were reported as responding dramatically to ECT. 
These findings from case studies, along with a review of other reports in the literature, lead these 
authors to conclude that ECT is safe and effective in individuals with ID who have comorbid 
psychiatric disorders (Aziz et al. 2001; Kessler, 2004).  
As mentioned earlier, identifying bipolar disorder in individuals with ID is difficult. 
Sovner (1989) among others have suggested that bipolar disorder may manifest differently in 
individuals with ID than in the general population (e.g., rapid cycling, chronic). Much of the 
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research on bipolar disorder in individuals with ID involves the examination of case reports, 
behavioral features associated with the illness, and pharmacological treatments. Although the 
hallmark feature of bipolar disorder is the waxing and waning of symptoms, the variation of 
symptoms in bipolar disorder in persons with intellectual disabilities has yet to be fully 
investigated. The present study sought to further develop the understanding of mania in 
individuals with ID by contrasting the presence and variation of manic symptoms in individuals 
with ID with comorbid bipolar disorder and those without bipolar disorder.  
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RATIONALE 
The purpose of this study was to characterize symptoms of mania over time in persons 
with bipolar disorder and ID. Given the limited data available on bipolar symptoms with 
individuals with ID, this was a preliminary descriptive study. Currently, the literature lacks a 
systematic investigation into what characterizes a change in mood among individuals with ID. In 
addition, little is understood in how this variation in behavior differs from individuals with ID 
without bipolar disorder. The present study aimed to extend the investigation of bipolar disorder 
in the intellectually disabled population in two ways. First, this research assessed the presence of 
manic symptoms in participants identified with and without bipolar disorder. Secondly, this 




Participants included residents from Pinecrest Developmental Center (PDC) in Pineville, 
Louisiana. PDC is a state-run facility that provides 24-hour supervision to over 550 individuals 
with varying levels of intellectual disability and adaptive functioning. All diagnoses were 
provided by licensed clinical psychologists and based on DSM-IV-TR criteria.  
Three groups of individuals with ID participated in this study: individuals with bipolar 
disorder, individuals with psychopathology other than bipolar disorder, and individuals with no 
psychopathology. The psychopathology group served as a validity control group to ensure that 
differences in the symptom variation between groups were due to the presence of bipolar 
disorder, and not the presence of psychopathology in general. The following criteria were used to 
select participants into their respective groups: 1) presence of a bipolar disorder diagnosis given 
by a licensed psychologist, and 2) criteria on DSM-IV checklist for the past occurrence of a 
manic episode. These criteria were chosen based on the inclusion criteria cited in the bipolar 
literature of the general population.  
There were 15 individuals with a diagnosis of bipolar disorder who met the inclusion 
criteria for this study (e.g., bipolar diagnosis confirmed by licensed psychologist and staff 
endorsement of symptoms on DSM-IV-TR checklist). However, one participant in the bipolar 
group had insufficient data in the archive (less than 75% or 27 monthly data points) and was 
dropped from the study. Therefore, the bipolar group comprised 14 individuals, the 
psychopathology group comprised 14 individuals, and the control group comprised 14 
individuals.  Thus, a total of 42 residents were included in this study. 
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Participants’ ages ranged from 30 to 78 years, with the average age of 53 years.  Nine 
participants (64.3%) in each group had limited verbal capacity. Results of a chi-square analysis 
indicated that the groups did not significantly differ on variables of age, ethnicity, gender, level 
of ID, verbal ability, or ambulation. Further, there were no significant differences between 
groups on the presence of hearing or visual impairments.  Demographic information is presented 
in Table 1. 
Table 1 
Demographic Characteristics of Groups (N=42) 
 
Characteristic    
 Bipolar (n=14) Psychopathology (n=14) Control (n=14) 
Age    
0-21 0 (0 %) 0 (0 %) 0 (0 %) 
22-45 4 (28.6 %) 6 (42.9 %) 5 (35.7%) 
46-65 7 (50.0 %) 6 (42.9 %) 6 (42.9 %) 
66+ 3 (21.4 %) 2 (14.2 %) 3 (21.4 %) 
Gender    
Female 9 (64.3 %) 6 (42.9 %) 9 (64.3 %) 
Male 5 (35.7 %) 8 (57.1 %) 5 (35.7 %) 
Race    
African American 2 (14.3 %) 3 (21.4 %) 2 (14.3 %) 
Caucasian 12 (85.7 %) 11 (78.6 %) 12 (85.7 %) 
 
 
  (table cont.) 
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Level of ID    
Severe 2 (14.3 %) 4 (28.6 %) 2 (14.3 %) 
Profound 12 (85.7 %) 10 (71.4 %) 12 (85.7%) 
Verbal Ability    
Verbal  5 (35.7 %) 5 (35.7 %) 5 (35.7 %) 
Non-Verbal 9 (64.3 %) 9 (64.3 %) 9 (64.3 %) 
Ambulation    
Ambulatory 11 (78.6 %) 12 (85.7 %) 9 (64.3 %) 
Non-Ambulatory 3 (21.4%) 2 (14.3 %) 5 (35.7 %) 
Hearing 
Impairments 
   
Yes 1 (7.1 %) 2 (14.3 %) 2 (14.3 %) 
No 13 (92.9 %) 12 (85.7 %) 12 (85.7 %) 
Visual 
Impairments 
   
Yes 0 (0 %) 3 (21.4 %) 2 (14.3 %) 
No 14 (100 %) 11 (78.6 %) 12 (85.7 %) 
 
Many participants had multiple axis I diagnoses. Thirteen of the bipolar participants had 
at least two axis I diagnoses, while the psychopathology groups had seven participants with 
multiple axis I diagnoses. These diagnoses were noted during the chart review and are listed in 
Table 2. Further, the most recent mood episode was noted during the chart review for 
participants in the bipolar group. Six of the bipolar participants had a most recent episode of 
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mania, three participants had a most recent episode of hypomania, and five participants had a 
diagnosis of bipolar NOS. 
Table 2 
Axis I Diagnoses across Groups 
 
Axis I diagnosis    
 Bipolar Psychopathology Control 
Anxiety Disorder 1 2 0 
Autistic Disorder 1 7 0 
Bipolar I Disorder 9 0 0 
Bipolar II Disorder 1 0 0 
Bipolar NOS 4 0 0 
Dementia NOS 2 0 0 
Dysthymic Disorder 0 1 0 
Encopresis 0 1 0 
Enuresis 0 1 0 
Major Depressive Disorder 0 1 0 
Obsessive Compulsive Disorder 0 1 0 
PDD NOS 5 2 0 
Pica 2 1 0 
Schizophrenia 0 1 0 
Stereotypic Movement Disorder 
(with SIB) 
5 5 0 
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As medication may have an impact on the presence and severity of symptoms, current 
medications were noted during the participant’s chart review. All participants in the bipolar and 
psychopathology groups were on psychotropic medications.  Approximately 71% of the bipolar 
group participants were prescribed multiple medications, whereas approximately 50% of the 
psychopathology group were prescribed multiple medications. Overall, the type of medications 
prescribed across the bipolar and psychopathology groups did not differ substantially. Only one 
participant in the control group was prescribed psychotropic medication (e.g., Zyprexa); this 
medication was being titrated at the time of the chart review. Table 3 lists the psychotropic 
medication prescribed to the participants at the time of the chart review.  
Table 3 
Psychotropic Medication Usage of Groups  
 
Medication Class  Frequency Count  
 Bipolar Psychopathology Control 
Anti-depressants    
Desyrel 1 0 0 
Remeron 0 1 0 
Paxil 1 1 0 
Anti-obsessional    
Luvox 0 1 0 
Anti-psychotics    
Abilify 1 1 0 
Risperdal 2 5 0 
   (table cont.) 
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Serequel 0 1 0 
Thorazine 1 2 0 
Zyprexa 6 3 1 
Anxiolitics    
Ativan 1 1 0 
Buspar 1 2 0 
Inderal 0 1 0 
Mood Stabilizer    
Depakote/Dapakene 6 2 0 
Limictal 0 1 0 
Lithium 1 0 0 
Tegretol 2 1 0 
Non-Stimulants    
Strattera 1 0 0 
 
Behaviors that were targeted in the participants’ behavior support plans were also noted. 
It was observed that the target behaviors largely focused on non-specific symptom control (e.g., 
‘bipolar symptoms’) in addition to other possibly unrelated maladaptive behaviors such as 
physical aggression, self-injury, and temper tantrums. All participants in the bipolar and 
psychopathology groups had target behaviors, while only six participants (approximately 43%) 
in the control group had a target behavior listed in their support plan. Specific behavioral targets 





Behavioral Targets of Groups 
 
Behavioral Target    
 Bipolar Psychopathology Control 
Anger Management 1 0 0 
Biting others 0 0 1 
Chewing  1 1 0 
Disruptive Behavior (chain 
of disruptive behaviors) 
3 2 0 
Elopement 1 0 0 
Food Theft 2 0 0 
Inappropriate Sexual 
Behavior 
1 0 0 
Inappropriate Toileting 0 1 0 
Motoric Behavior 0 1 0 
Noncompliance 0 0 1 
Pica 2 1 0 
Refusing to walk/crawling 1 0 1 
Rumination 0 1 0 
SIB 6 8 2 
Sleep Disturbance  1 0 0 
Stereotypies 0 1 0 
   (table cont.) 
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Stripping 0 1 0 
Tantrums 1 6 3 
Threatening Others 0 0 1 
Physical Aggression 4 6 2 
Verbal Aggression 2 1 0 
Note. Many participants had multiple target behaviors. Only specific behavioral targets are listed 
in Table 4, as the non-specific symptoms of disorders are redundant with Axis I information 
listed in Table 2.  
 
Participant Selection 
Residents were assigned to the bipolar group if they met the following criteria: 1) a chart 
review revealed that the individual was given a diagnosis of bipolar disorder by a licensed 
psychologist; and, 2) ratings on the DSM-IV checklist indicated the individual met criteria for 
the past occurrence of one or more manic episodes. Further, all diagnoses of bipolar disorder 
were re-confirmed by the licensed psychologist currently assigned to the participants’ case. 
Individuals selected into the psychopathology group were those that met the following criteria: 
1) a chart review revealed that the individual had an Axis I diagnosis other than bipolar disorder; 
2) ratings on the DSM-IV checklist indicated that the individual did not meet criteria for the past 
occurrence of manic episodes; and, 3) demographic variables including age, gender, level of ID, 
verbal ability, and ambulation were similar to individuals in the bipolar group. Control group 
participants were selected based on: 1) a chart review that revealed that the individual had no 
Axis I diagnosis; 2) ratings on the DSM-IV checklist that indicated that the individual did not 
meet criteria for the past occurrence of a manic episode; and, 3) demographic variables including 
age, gender, level of ID, verbal ability, and ambulation were similar to individuals in the bipolar 
group. 
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DSM-IV Checklist. Since the focus of this investigation was the presence and variability 
of manic symptoms over time, the DSM-IV-TR checklist was structured to focus on the past 
occurrence of a manic episode. As defined in the DSM-IV-TR (APA, 2000), to meet criteria on 
the checklist, the direct care informant had to endorse the presence of a distinct period of 
abnormally and persistently elevated symptoms of expansiveness or irritable mood lasting at 
least one week. The informant must have also indicated that during this mood disturbance there 
were specific symptoms, including at least three of the following: inflated self-esteem or 
grandiosity; decreased need for sleep; more talkative than usual or pressure to keep talking; flight 
of ideas or subjective experience that thoughts are racing; distractibility; increase in goal-directed 
activity or psychomotor agitation; and excessive involvement in pleasurable activities that have a 
high potential for painful consequences. Additionally, the informant had to endorse that during 
this mood disturbance the individual was difficult to manage or harder to care for than when not 
in a disturbed mood. The DSM-IV checklist is included as an appendix.  
Measures 
The present study used two measures to identify items as dependent measures of mania: 
1) Parent Version of the Young Mania Rating Scale (P-YMRS); and 2) the Diagnostic 
Assessment for the Severely Handicapped-II (DASH-II).  
Parent Version of Young Mania Rating Scale (P-YMRS)  
The Young Mania Rating Scale (YMRS) is a well-known, commonly used, valid and 
reliable measure of mania recognized in the general population literature. This 11-item scale is 
typically used to assess the severity of mania in patients with bipolar disorder. The items are: 
elevated mood, increased motor activity energy, sexual interest, sleep, irritability, speech (rate 
and amount), language (thought disorder), content, disruptive-aggressive behavior, appearance, 
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and insight. It was designed to be a clinician-rating scale for persons without ID (Young, Biggs, 
Ziegler, & Meyer, 1978).  
Recently, a parent version of the YMRS (P-YMRS) has been developed to assess bipolar 
disorder in youths. The P-YMRS is based on the original 11-item YMRS, but is in an adapted 
questionnaire format. The P-YMRS has been shown to accurately discriminate between 
individuals with bipolar disorder, unipolar disorder, and other diagnoses (Gracious, Youngstrom, 
Findling, & Calabrese, 2002). Gracious, Youngstrom, Findling, and Calabrese (2002) report 
acceptable internal consistency (.72) and good diagnostic efficiency (classification rates 
exceeding 78%), and high correlations with the original YMRS (r = .97). The total score range 
from 0-60. The average scores in the P-YMRS validity study were approximately 25 for mania 
and 20 for hypomania. The authors note that any score above 13 indicated a potential case of 
mania or hypomania, whereas any score above 21 was a probable case (Gracious, Youngstrom, 
Findling, & Calabrese, 2002). The P-YMRS was chosen for the present study because the YMRS 
is widely recognized in the literature, it has been shown to be reliable and valid, it can be used as 
an informant-based measure, it offers items that are scored on a Likert scale, and many items 
target observable behavior (Youngstrom, Gracious, Danielson, Findling, & Calabrese, 2003). 
The P-YMRS was administered to direct-care staff as an informant-based mania rating scale. 
Diagnostic Assessment Severely Handicapped (DASH-II) 
The DASH-II is an informant-based screening tool designed to evaluate psychopathology 
of individuals with severe and profound ID (Matson, 1995). This measure has been designed and 
validated for use with individuals with intellectual deficits. It is based on observable behaviors 
that can be reported by an informant who is familiar with the individual with ID.  
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This rating method consists of 84 items across 13 subscales representing major 
psychiatric disorders: 1) Anxiety, 2) Depression, 3) Mania, 4) PDD/Autism, 5) Schizophrenia, 6) 
Stereotypies, 7) Self-injury, 8) Elimination, 9) Eating, 10) Sleep, 11) Sexual, 12) Organic, and 
13) Impulse. The DASH-II has good psychometric properties, inter-rater reliability is .86 and 
test-retest reliability is .84 (Matson, 1995). Many of the subscales of the DASH-II have been 
validated in previous research with a severe and profound ID population (e.g., PDD/Autism, 
Depression, and Mania subscales; Matson & Smiroldo, 1997; Matson, Smiroldo, & Hastings, 
1998; Matson, et al. 1999).  
Mania Subscale of the DASH-II 
The Mania subscale is one of the 13 subscales of the DASH-II. Items on this subscale 
include: is restless or agitated, has a decreased need for sleep, is cranky or irritable, is easily 
distracted, is extremely happy or cheerful for no obvious reason, talks loudly, and talks quickly. 
Matson and Smiroldo’s (1997) validation study on this subscale reported rates of internal 
consistency correlations ranging from .42 to .76. Further, a discriminate analysis correctly 
classified 90.9 % of the manic individuals and 100 % of the controls using DSM-IV diagnoses as 
the criteria for group assignments. Additionally, the individual items of the Mania subscale (r = 
.43 to .91) and the total subscale score (r = .94) were significantly correlated with DSM-IV 
diagnosis. Thus, the DASH-II was administered to direct-care staff as an informant-based rating 
scale. 
As identifying mania in this population remains a challenge for researchers and 
clinicians, two measures were referenced as indicators of mania for this study: the P-YMRS and 
the Mania subscale of the DASH-II. The P-YMRS was used as a criterion measure. There were 
five participants whose P-YMRS score reached 21 or above (e. g. ‘probable case of mania’; 
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Gracious, Youngstrom, Findling, & Calabrese, 2002). These participants’ total P-YMRS score 
was correlated with their DASH-II item scores. Items of the DASH-II that were correlated with 
the criterion measure (P-YMRS) at .35 or higher were included in a derived subscale of the 
DASH-II. This P-YMRS derived subscale was called the Criterion-referenced subscale for the 
purpose of this study. The Mania subscale of the DASH-II was the alternative dependent 
measure of mania.  In addition, two other subscales, the Pervasive Developmental Disorder 
(PDD) and Schizophrenia subscales of the DASH-II, were included in the analysis to serve as 
comparative anchor points for the examination of consistency of the mania measures. PDD 
symptoms are assumed to be stable over time.  However, the course of schizophrenia symptoms 
commonly fluctuates with stress induced by the environment (APA, 2000; Reid, 1989). As the 
presence or absence of symptom fluctuation of PDD and schizophrenia have been recognized 
(e.g., DSM-IV-TR, APA, 2000) and should not significantly differ between the case groups, the 
serial correlation coefficients of these subscales served as indicators to whether the variability in 
the Mania and Criterion-referenced subscales are due to actual vacillation in symptoms or 
assessment error.  
Hypothesis 
Patterns of means and serial correlations across subscales were hypothesized for each 
group. It was assumed that assessing the patterns of means and serial correlations across the 
subscales would provide a validity estimate of subscale mean endorsements and serial 
correlations (Campbell & Fiske, 1959). A higher mean endorsement of manic symptoms on the 
Mania and Criteria-referenced subscales was anticipated for the bipolar group over the other two 
groups. Further, it was expected that the bipolar and psychopathology group would have 
comparable endorsements on the PDD and Schizophrenia subscale, while the control group 
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would have fewer endorsements on these subscales because these individuals have no Axis I 
diagnoses.  
Moreover, it was expected that the bipolar group’s serial correlation on the Mania and 
Criterion-referenced subscales would diverge with the other two groups because their manic 
symptoms would wax and wane over time, and thus yield a low serial correlation.  The other 
groups were hypothesized to consistently have few manic symptoms and thus, have a high serial 
correlation on these subscales. For the Schizophrenia subscale, it was assumed that the bipolar 
and psychopathology groups would converge with low serial correlations since both groups may 
have some schizophrenia-like symptoms that vacillate over time.  Moreover, it was expected that 
the control group would consistently have few symptoms endorsements on this subscale and 
yield a high serial correlation. Finally, it was hypothesized that all three groups would have 
consistent symptoms endorsements, or a high serial correlation, on the PDD subscale since 
symptoms of PDD should be stable overtime.  Table 5 displays the hypothesized pattern of serial 
correlations across subscales.  
Table 5  
Hypothesized Pattern of Serial Correlations across Subscales 
 
  Case Group  
Subscale Bipolar Psychopathology  Control  












   (table cont.) 
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The DSM-IV Checklist, DASH-II, and P-YMRS data were collected from direct-care 
staff familiar with the participants for a minimum of six months prior to the study. All 
instruments were administered to the same staff person for each resident to control for inter-rater 
error between instruments. The bipolar group and psychopathology group were selected based on 
the aforementioned criteria. Data for controls were collected shortly after individuals in the 
bipolar group had been selected. The author, who was trained in the administration of these 
assessment measures as outlined in their respective manuals, collected this data within a period 
of a month. Data collection and storage were conducted in accordance with accepted procedures 
to secure patient confidentiality. Retrospective DASH-II data was obtained from a main database 
for the designated three year time period (January 2002 - January 2005).  
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EXPERIMENTAL DESIGN 
 Maximum likelihood estimation was employed to test the null hypothesis that there is no 
significant difference between the variance/covariance structures of the case groups.  First, a 
model, termed the restricted model, was fit to the data of all the groups. Then, a second model, 
termed the general model, was fit to each group separately. Restricted Maximum Likelihood was 
used to estimate these models. The difference of the restricted model from the general model was 
then compared to the X2 table as an omnibus test.  In the case that the omnibus comparison was 
not significant, no further analyses were conducted. 
In the case that this maximum likelihood estimation procedure yielded a significant X2 
statistic, group estimated marginal means and serial correlations were then compared post-hoc. 
The post hoc comparison for the serial correlation was calculated by taking the difference of the 
group parameters and dividing it by the standard error of the parameters (Ullman, 2001). These 




The annual data included three data points for each participant, one from each year 2002, 
2003, and 2004 (including data collected at the time of study in January 2005). Annual data were 
data points that were collected during the same month and year for participants matched across 
groups. This approach was used to ensure that the time of assessment did not differ between 
groups. When three common data points could not be found in the archival database, data from 
January 2005 was used, since most participants had data collected during this month. There was 
one case when data across the matched triad did not coincide for month and year and in this 
instance, data from the prior month was used. Thus, all annual data points were collected within 
a two-month period for participants matched across groups. The time interval between annual 
data points ranged from 9 months to 22 months. One participant in the control group had only 
two annual data points due to missing data in the archive.  
The maximum likelihood estimation procedure was used with each subscale. The 
restricted models testing the null hypothesis, that there were no significant differences between 
groups, was rejected for the Mania, X2 (8, N=42) = 27.913, p<.001; Criterion referenced, X2 = (8, 
N=42) = 47.25, p<.001; and PDD subscales, X2 (8, N=42) = 24.41, p<.005. Model convergence 
could not be achieved for the Schizophrenia subscale.  Further inspection of the data revealed 
that there was not enough variability in the Schizophrenia subscale for the control group during 
the second year. All symptom endorsements on this subscale for the control group in the year 
2003 were zero.  
Post hoc pair-wise comparisons were conducted with the estimated marginal group 
means for the three significant subscales. A Bonferroni correction procedure was used to protect 
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against inflation of family-wise error rate. Bonferroni type adjustments are made by assigning 
alpha for each DV, so that overall alpha for the total set of dependent variables does not exceed 
some critical value (Tabachnick & Fidell, 2001). Significant mean differences were found on the 
Mania subscale, F (2, 45) = 9.26, p<.001. The bipolar and psychopathology groups had 
significantly higher mean endorsements on the Mania subscale than the control group, p<.001 
and p=.02, respectively.  The difference between the bipolar and psychopathology groups were 
non-significant (p=.07). Significant mean differences were also found for the Criterion-
referenced subscale, F (2, 42) = 11.22, p<.001. The bipolar group had a significantly higher 
mean endorsement than the psychopathology group, p=.03; and the control group, p<.001. The 
difference between the psychopathology and control groups was non-significant.  There was also 
a significant mean difference found for the PDD subscale, F(2, 51) = 8.86, p<.001. As expected, 
both the bipolar and psychopathology groups had a higher mean endorsement on the PDD 
subscale than the control group, p<.001 and p=.02, respectively. The mean difference between 
the bipolar and psychopathology groups was non-significant (p=.60). Estimated marginal group 
means and standard deviations for these subscales are displayed in Table 6.  
Table 6  
Estimated Marginal Subscale Means by Group 
 
 Case Group 
 Bipolar Psychopathology   Control 
Subscale M SD M SD M SD 
Mania 3.36a .44 2.71b .44 1.20a, b .44 
Criterion-referenced 7.61a, b .90 4.23a .90 1.56b .91 
      (table cont.) 
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PDD 3.61a .41 2.87b .41 1.22a, b .41 
Schizophreniaa - - - - - - 
Note. Means in a row sharing subscripts are significantly different at p<.05 using a Bonferroni 
correction. For all subscales, higher means indicate higher symptom endorsements. 
a Model convergence criteria could not be achieved for the Schizophrenia subscale. Estimated 
likelihood ratios could not be reliably calculated.  
 
Post hoc pair-wise comparisons were also conducted with the serial correlations of the 
groups for all four subscales. Again, Bonferroni procedures were used to protect against inflation 
of family wise error rate due to multiple comparisons. As these calculations were done by hand, 
alpha was adjusted to a significance level of p=.02.  No significant differences were found 
between the serial correlations between groups on the Mania subscale: p=.25 (bipolar compared 
to psychopathology); p=.22 (psychopathology compared to control);and p=.08 (bipolar compared 
to control). Further, no significant differences were found between the serial correlations 
between groups on the Criterion-referenced subscale: p=.26 (bipolar compared to 
psychopathology); p=.14 (psychopathology compared to control); and p=.04 (bipolar compared 
to control). However, a difference was found on the PDD subscale. The control group had a 
significantly higher serial correlation than the psychopathology group z=2.59, p=.005. The serial 
correlations for each group are displayed in Table 7.  
Table 7.   
Serial Correlations for Each Subscale by Group 
 
 Case Group 
 Bipolar Psychopathology  Control  
Subscale Rho SD Rho SD Rho SD 
Mania .42 .17 .26 .18 .04 .21 
      (table cont.) 
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Criterion-referenced .48 .16 .33 .18 .04 .20 
PDD .09 .19 -.14a .20 .51a .16 
Schizophreniaa - - - - - - 
Note. Correlations in a row sharing subscripts are significantly different at p<.02. For all 
subscales, higher correlations indicate higher serial correlations. 
a Model convergence criteria were not achieved for the Schizophrenia subscale. Estimated 
likelihood ratios could not be calculated reliably.  
 
 As the serial correlations of both the Mania and Criterion-referenced subscales for the 
control group were extremely low (.04), a floor effect was suspected. The descriptive statistics 
and frequency data of the two subscales for each group were computed. For the control group, 
the Mania subscale scores ranged from 0 to 6, while the other groups’ scores ranged from 0 to 10 
(maximum possible score of 14). Of the 41 annual data points (1 missing) for the control group, 
48.8% had a Mania subscale score of 0. Further, 80.5% of the control group’s data points had a 
total Mania subscale of 2 or below. 
 The Criterion-referenced subscale frequency and descriptive statistics data indicated 
similar findings. The control group’s scores on the Criterion-referenced subscale ranged from 0-
14, while the psychopathology and bipolar groups’ scores ranged from 0 to 17 and 0 to 26, 
respectively. Of the control group’s 41 data points (1 missing), 53.7% had a criterion-referenced 
subscale score of 0. Further, 75.6% of these data points had a subscale score of 2 or below. These 
descriptive statistics indicate restricted range of scores in the mania and Criterion-referenced 
subscales for the control group. 
 In order to get a better estimate of the means and serial correlations for the Schizophrenia 
subscale, the estimated likelihood procedure and pair-wise comparisons were re-calculated 
without data from year 2 for all subscales. Convergence criteria were achieved for all subscales. 
The restricted models testing the null hypothesis, that there were no significant differences 
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between groups, was rejected for the Criterion-referenced, X2 = (8, N=42) = 26.90, p<.001; and 
Schizophrenia subscales, X2 (8, N=42) = 38.80, p<.001. The null hypothesis was not rejected for 
the Mania, X2 (8, N=42) = 14.42, n. s.; and the PDD subscales, X2 (8, N=42) = 8.51, n. s. 
Pair-wise comparisons of estimated marginal means were conducted for the Criterion-
referenced and Schizophrenia subscales. A Bonferroni correction procedure was used. A 
significant mean differences was found on the Criterion-referenced subscale, F(2, 31) = 5.84, 
p=.005. The bipolar group had a significantly higher mean endorsement than the control group 
on this subscale, p<.01. Mean differences between the bipolar and psychopathology groups, and 
psychopathology and control groups, were non-significant, p=.10 and p=.77, respectively. No 
significant mean differences were found between groups on the Schizophrenia subscale. 
Estimated marginal subscale means excluding data from year 2 are displayed in Table 8. 
Table 8 
Estimated Marginal Subscale Means by Group (excluding 2003) 
 
 Case Group 
 Bipolar Psychopathology   Control 
Subscale M SD M SD M SD 
Mania 3.56 .52 2.65 .52 1.43 .52 
Criterion-referenceda 7.54a 1.20 3.80 1.20 1.86a 1.20 
PDD 3.39 .50 2.86 .50 1.46 .50 
Schizophreniaa 1.86 .39 .66 .39 .60 .39 
Note. Correlations in a row sharing subscripts are significantly different at p<.005. For all 
subscales, higher correlations indicate higher serial correlations. 
a Significant omnibus test.  
Pair-wise comparisons were also conducted with the serial correlations of the Criterion-
referenced and Schizophrenia subscales. Alpha was adjusted to p=.02 to protect against inflation 
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of family-wise error rate (Tabachnick & Fidell, 2001). Significant differences were found 
between the serial correlations on the Criterion-referenced subscale. The bipolar group had a 
significantly higher serial correlation than the control group, p=.01. The difference between the 
bipolar and psychopathology group was non-significant (p=.03). No significant differences were 
found on the Schizophrenia subscale: p=.14 (bipolar compared to psychopathology); p=.43 
(psychopathology compared to control); p=.06 (bipolar compared to control). As the serial 
correlations of the Schizophrenia subscale for the control group were low (-.12), a floor effect 
was suspected. The descriptive statistics and frequency data of this subscale for each group were 
computed. For the control group, the Schizophrenia subscale ranged from 0 to 9. Of the control 
group’s 41 total annual data points (1 missing), 82.9% had a Schizophrenia subscale score of 0. 
Further, with the exclusion of year 2003 (28 data points), 75.0% of the control group’s of the 
data had a total Schizophrenia subscale endorsement of zero. The serial correlations for each 
group excluding data from 2003 are displayed in Table 9.  
Table 9 
Serial Correlations for Each Subscale by Group (excluding 2003) 
 
 Case Group 
 Bipolar Psychopathology  Control  
Subscale Rho SD Rho SD Rho SD 
Mania .53 .20 .03 .27 -.02 .30 
Criterion-referenceda .79a .10 .29 .25 .13a .27 
PDD .18 .26 .13 .27 .19 .31 
Schizophreniaa .44 .23 .06 .27 -.12 .27 
Note. Correlations in a row sharing subscripts are significantly different at p<.02. For all 
subscales, higher correlations indicate higher serial correlations. 
aSignificant omnibus test. 
 61
Monthly Analysis 
 The monthly analysis included data from each month for three years, January 2002 – 
January 2005.  Although some participants did have missing data, all had at least 75% or 27 data 
points out of the maximum 37 monthly data points. The maximum likelihood estimation 
procedure was used with each subscale. The restricted model testing the null hypothesis that 
there were no significant differences between the groups was  rejected for the Criterion-
referenced, X2 (38, N=42) = 120.45, p<.001, and Schizophrenia subscales, X2 (38, N=42) = 
142.45, p<.001. The null hypothesis was not rejected for the Mania, X2 (38, N=42) = 52.17, n. s., 
and the PDD subscales, X2 (38, N=42) = 36.01, n. s. 
 Post hoc pair-wise comparisons were conducted with the estimated marginal group 
means for the Criterion-referenced and Schizophrenia subscales. A significant mean difference 
was found on the Criterion-referenced subscale, F(1, 156) = 51.07, p<.001. The bipolar group 
had a significantly higher mean endorsement on the Criterion-referenced subscale than the 
psychopathology group. A significant mean difference was also found on the Schizophrenia 
subscale, F (1, 6) = 10.08, p=.02. The bipolar group had a significantly higher mean endorsement 
on the Schizophrenia subscale than the psychopathology group. Estimated marginal group means 
and standard deviations are displayed in Table 10.  
Table 10 
Estimated Marginal Subscale Means by Group 
 
 Case Groups 
 Bipolar Psychopathology 
Subscale M SD M SD 
    (table cont.) 
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Mania 3.68 .13 2.56 .13 
Criterion-referenced a, b 6.17 .25 3.69 .24 
PDD 3.06 .12 2.63 .12 
Schizophrenia a, b 1.40 .12 1.00 .02 
Note. For all subscales, higher means indicate higher symptom endorsements. 
a Significant omnibus tests. b Significant group difference. 
 Post hoc pair-wise comparisons for the serial correlations were also conducted for the 
Criterion-referenced and Schizophrenia subscales.  A significant difference was found between 
the bipolar and psychopathology group on the Criterion-referenced subscale, z=2.09, p=.02. The 
bipolar group had a significantly higher serial correlation than the psychopathology group. The 
difference between the bipolar group and the psychopathology group on the Schizophrenia 
subscale was non-significant. The serial correlations for each group are displayed in Table 11. 
Table 11 
Serial Correlations for Each Subscale by Group 
 
 Case Group 
 Bipolar Psychopathology 
Subscale Rho SD Rho SD 
Mania .14 .05 .04 .06 
Criterion-referenceda, b .30 .05 .14 .06 
PDD .04 .05 .01 .05 
Schizophreniaa .42 .05 .35 .06 
Note. For all subscales, higher correlations indicate higher serial correlations.  




 Manic symptoms were evaluated over time in three groups of individuals with intellectual 
disabilities: a group diagnosed with bipolar disorder, a group diagnosed with psychopathology 
other than bipolar disorder, and a group with no Axis I diagnosis. The Mania subscale of the 
DASH-II, and a subscale derived from the P-YMRS were the two dependent measures of mania. 
The derived subscale from the P-YMRS was called the Criterion-referenced subscale for the 
purpose of this study. Manic symptoms were evaluated in two ways: 1) symptom presence (mean 
score), and 2) consistency over time (serial correlation).  
Manic symptoms were first evaluated on an annual basis over a period of three years.  
The estimated marginal means across groups were consistent with the hypotheses despite a few 
exceptions. It was expected that the bipolar group would have significantly greater symptoms 
endorsements on both the Mania and Criterion-referenced subscales than the other two groups. 
However for the Mania subscale, the bipolar group had significantly more symptoms 
endorsements than the control group but not the psychopathology group. Further, the 
psychopathology group had significantly more symptom endorsements than the control group. 
However, there was no significant difference between the bipolar and psychopathology groups. 
For the Criterion-referenced, the bipolar group had significantly more symptoms endorsements 
than both the psychopathology and control groups. One reason why the results on the Criterion-
referenced subscale were as expected, while the Mania subscale was not, may be the fact that the 
Criterion-referenced subscale had significantly more items than the Mania subscale. Perhaps it 
was more sensitive to symptoms distinct to mania rather than symptoms exhibited with general 
psychopathology.   
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The mean scores on the PDD subscale were as expected. There were more symptom 
endorsements for the bipolar and psychopathology groups than the control group. This was not 
surprising as both the bipolar and psychopathology groups had various Axis I diagnoses 
(including those in the PDD spectrum), while the control group had no Axis I diagnoses. 
As far as the Schizophrenia subscale, convergence was not achieved for the model. 
Further inspection of the data revealed that there were no symptoms endorsements in the annual 
data for 2003 for control participants. This artifact in the data resulted in limited variability in the 
cell, and thus convergence was not achieved. To better examine this data, the annual data were 
re-analyzed without data from year 2003 for all groups and subscales.  A similar pattern to what 
was observed in the full analysis resulted from this analysis of group means. Convergence was 
achieved for all subscales. However, only the Criterion-referenced and Schizophrenia subscales 
resulted in significant omnibus tests. It is somewhat surprising that there was not a significant 
difference between the bipolar and the psychopathology groups on the Criterion-referenced 
subscale. Although not significant, it may be noted that the mean of the bipolar group was quite 
larger than the psychopathology group on this subscale. There was no significant difference in 
estimated marginal group means on the Schizophrenia subscale. 
Next, the serial correlations of the annual data points were evaluated across groups. The 
results of this analysis were quite different than what was hypothesized. First, the patterns of the 
serial correlations for the Mania and Criterion-referenced subscales were unexpected. Contrary 
to the hypotheses, the bipolar group had higher, though not significant, serial correlations than 
the other two groups on these subscales. Further, the control group, which was expected to have 
highly consistent endorsements over time, had very low serial correlations.  
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An analysis of the descriptive statistics indicated a floor effect for the control group on 
these two subscales. Approximately half of the annual data points on the Mania subscale, and 
over half of the annual data points for the Criterion-referenced subscale for the control group, 
had no symptom endorsements. Though this descriptive information does explain the low serial 
correlation coefficient for the control groups, it does not clarify the relatively higher serial 
correlation coefficients for the bipolar group over the psychopathology group.  
Moreover, the comparative anchor scales (PDD and Schizophrenia) yielded an 
unexpected pattern of results.  For the PDD subscale, the bipolar and psychopathology groups 
had very low serial correlations. The control group, on the other hand, had a high serial 
correlation, significantly higher than the psychopathology group. All three groups were 
hypothesized to have high serial correlations on the PDD subscale, as symptoms of PDD should 
be stable over time (DSM-IV-TR, APA, 2000). However, the pattern of serial correlations 
suggests poor convergent validity across groups.  It is difficult to explain why symptoms that 
should be stable over time have low serial correlations for two groups but high ones for another 
group. 
The Schizophrenia subscale, as previously mentioned, did not achieve model 
convergence when the full data set was analyzed. Thus, the serial correlation data were examined 
without the data from year 2003. This pattern of correlations was also unexpected. The bipolar 
group had a relatively high serial correlation on this subscale when compared to the low serial 
correlations of the psychopathology and control groups, although this difference was not 
significant. The bipolar and psychopathology groups were hypothesized to have low serial 
correlations for the Schizophrenia subscale. These groups were expected to illustrate convergent 
validity on this subscale because fluctuation of symptoms was anticipated in these two groups. 
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Further, it was expected that the control group would be a measure of divergent validity for this 
subscale. It was anticipated that the control group would have a high serial correlation or highly 
consistent symptom endorsement on this subscale; however, due to a lack of symptoms, a floor 
effect was observed. As with the Mania and Criterion-referenced subscales, a descriptive 
analysis of the data revealed a floor effect for the control group on the Schizophrenia subscale. 
Approximately 83% of the annual data points (including year 2003) for the control group had no 
schizophrenia symptom endorsements, and 75% of the control group’s annual data excluding 
year 2003 had no schizophrenia symptom endorsements. Again, while this descriptive 
information clarifies the unexpected low coefficient for the control group, it does not explain the 
other discrepant findings.  
Although descriptive statistics elucidate the unexpected findings of the control group on 
three of the four subscales, the patterns of serial correlations for the bipolar and psychopathology 
groups are difficult to explain. It remains unclear why there are low correlation coefficients for 
both the bipolar and psychopathology groups on the PDD subscale, which characterizes 
symptoms of PDD that should remain stable over time. Also, it is unclear why the bipolar group 
has relatively high correlation coefficients on subscales that characterize symptoms that should 
fluctuate over time, such as the Mania, Criterion-referenced, and Schizophrenia subscales.  
One possible explanation for these unexpected patterns of serial correlation is that 
evaluation of annual data points (one assessment per year) may not be sensitive to the changes in 
symptoms over time.  It may be necessary to have assessments that are more proximal in time to 
detect fluctuation in manic symptoms.  It is not inconceivable that many of the participants were 
exhibiting comparable frequency of symptoms of mania at the three points in time.  Thus, 
evaluation of these patterns with more frequent monitoring of manic symptoms was warranted. 
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Therefore, to examine this possibility further, monthly symptom assessments were evaluated for 
the two groups that had mania symptom endorsements: bipolar and psychopathology groups.  
Monthly assessments across the four subscales were evaluated. The Criterion-referenced 
and Schizophrenia subscales resulted in significant omnibus tests. The estimated marginal means 
and serial correlations of these subscales were further evaluated with pair-wise comparisons. 
 Similar to what was observed with the annual data, the bipolar group had a significantly 
higher estimated marginal mean than the psychopathology group on the Criterion-referenced 
subscale. This difference was quite large. This further supports the notion that the Criterion-
referenced subscale may be more sensitive to symptoms of mania than the Mania subscale, 
which resulted in a non-significant omnibus test. Again, the Criterion-referenced subscale 
included more items than the Mania subscale and appears to better differentiate the bipolar group 
from the psychopathology group.  
Statistically significant differences were also found on the Schizophrenia subscale. 
However, it would be difficult to argue a true clinical difference on this subscale between the 
bipolar and psychopathology groups as the means were 1.40 and 1.00, respectively. There were 
extremely low standard deviations for these means, therefore statistically they were significantly 
different. However, clinically there is no true difference between these groups on this 
Schizophrenia subscale.  
The pattern of serial correlations across the subscales was examined. Like the annual 
data, the pattern of serial correlations was higher for the bipolar group than the psychopathology 
group across the Mania and Criterion-referenced subscales. These patterns are inconsistent with 
the original hypotheses, but echo the annual findings.  There is relatively high symptoms 
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consistency in manic symptoms for the bipolar group, which were expected to fluctuate over 
time. 
Serial correlations are similar across groups for the PDD and Schizophrenia subscales. 
That is, the serial correlations on the PDD subscale were low for both groups. Further, both the 
bipolar and psychopathology groups had moderate serial correlations on the Schizophrenia 
subscales, .42 and .35 respectively (Osborne, 2003).  The relatively high serial correlation on 
Schizophrenia subscale is one difference between the monthly and annual serial correlation 
analyses. Similar scores across groups on these subscales were expected; however, the 
coefficients are in the opposite direction than was anticipated. Both groups had high coefficients 
on the Schizophrenia subscale, and low coefficients on the PDD subscale.  Thus, it appears that 
there was low consistency in symptom endorsement for PDD symptoms, which were assumed to 
be stable over time. There was also high consistency in symptoms endorsement for schizophrenia 
symptoms, which were assumed to fluctuate over time.  
Pair-wise comparisons were only conducted for the Criterion-referenced and 
Schizophrenia subscales. The bipolar group had a significantly higher serial correlation than the 
psychopathology group on the Criterion-referenced subscale. That is, the bipolar group had a 
significantly more consistent endorsement of mania items than the psychopathology group. This 
finding is inconsistent with the original hypothesis, but is in-line with the results of the annual 
data serial correlations. There was no significant difference between the groups’ serial 
correlations on the Schizophrenia subscale. 
Overall, similar patterns of means and serial correlations were observed across the annual 
and monthly data analyses. As hypothesized, the bipolar group had higher mean endorsements of 
manic symptoms on the Criterion-referenced subscale than the other groups.  Further, the bipolar 
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group had a high serial correlation or consistent symptom endorsements for manic symptoms, 
which were expected to fluctuate over time. This finding was unexpected. There are several 
possible explanations for these unanticipated results.  
 First, perhaps symptoms of mania in the ID population are more chronic than in the 
general population. Therefore, staff endorsed symptoms of mania at each assessment because 
they are always present or were present in the last two weeks (e.g., similar to cyclothymia but do 
meet criteria for manic episode). This explanation would support previous suggestions by Sovner 
(1989) that mood disorders in the ID population may be more chronic or rapid cycling.  
A second, and perhaps more plausible explanation, is that staff perceive symptoms of 
mania as consistently present and are unlikely to accurately report when the symptoms were last 
observed.  A common criticism of indirect assessment is that informants may not be motivated, 
trained, or competent enough to respond accurately (Lalli, Browder, Mace, & Brown, 1993; 
Sturmey, 1996). The staff’s work schedule often changes to compensate the needs of the home. 
Therefore, staff may not work the same time on the same day every week or even with the same 
individuals. Thus, they may know that the participant exhibits these symptoms but is unable to 
reliably report when it has last occurred.   
A third possible explanation for the unexpected pattern of serial correlations is that the 
DASH-II may not be sensitive to symptom fluctuation over time. The DASH-II was intended to 
be a screening measure of psychopathology for individuals with ID. That is, it was originally 
designed to screen individuals for psychopathology so that a clinician could further evaluate 
individuals who had symptom endorsements one standard deviation above the mean (Matson, 
1995). As the DASH-II was not originally designed to track symptoms over time, perhaps it is 
 70
not sensitive to change in symptoms and thus unable to detect true vacillation in manic 
symptoms.   
Further, the Criterion-referenced subscale was based on the data of only five participants 
(those with a P-YMRS score of 21 or above). While Gracious, Youngstrom, Findling, & 
Calabrese (2002) state that any score above 21 indicates a probable case of mania, this cut-off 
may be somewhat conservative for a descriptive study such as this. In addition, some of the items 
of the P-YMRS, particularly those relying on verbal and cognitive abilities, were not endorsed 
for these individuals (i.e. Has your child shown changes in his/her thought patterns?; Is your 
child talking more quickly or more than usual?; Is your child talking about different things than 
usual?).  As a result, there may have been an under-identification of current mania for these 
participants. Moreover, as few current mania cases were identified with the P-YMRS, the 
coefficients of the criterion-referenced subscale may be less stable than desired. These 
limitations should be taken into consideration when reflecting on the present findings and 
pursuing further research in this area.  
While diagnosing bipolar disorder in individuals with intellectual disabilities is often a 
challenge, the results of the present evaluation of manic symptoms indicated that the bipolar 
group significantly differed from other groups on observable symptoms of the Criterion-
referenced subscale, such as head banging, sleep difficulties, public masturbation and verbal 
abusiveness.  This finding is in line with previous findings suggesting that clinicians can focus 
on observable symptoms in cases when DSM-IV criteria are not applicable (Sturmey, Laud, 
Cooper & Matson, 2004). Moreover, results of the current investigation lend support to previous 
suggestions that mood disorder symptoms, specifically symptoms of mania, are more chronic or 
rapid cycling in the ID population than what is observed in the general population (Sovner, 
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1989). However, this conclusion should be taken cautiously as the explanation for the present 
findings are called into question by the unanticipated results on the comparative subscale (PPD 
and schizophrenia). In order to clarify these findings, research is needed to examine the ability of 
staff to accurately report the frequency of symptom presentation during specified periods of time. 
Future research should continue to examine mania in the intellectually disabled population in 
hopes of deriving tools that aid clinicians and researchers in the diagnosis and treatment of 
bipolar disorder in this population.  
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DSM-IV BIPOLAR CHECKLIST 
 
Please indicate “yes” or “no” if these statements have ever applied to the individual in question.  
If a statement is not applicable to an individual, please indicate “n/a”. 
 
Y or N 
____ 1. A distinct period of abnormally and persistently elevated, expansive or irritable mood 
lasting at least one week? 
 
____    2. Is the individual difficult to manage or harder to care for during this mood disturbance 
than when not in a disturbed mood? 
 
During this period of abnormal mood, have you observed the individual with the following 
symptoms: 
 
____ 1. Inflated self-esteem or grandiosity 
 
____ 2. Decreased need for sleep (seems rested after only 3 hours of sleep)  
 
____ 3. More talkative than usual or pressure to keep talking 
 
____ 4. Flight of ideas or subjective experience that thoughts are racing 
 
____ 5. Distractibility (attention too easily drawn to unimportant or irrelevant external stimuli) 
 
____ 6. Increase in goal-directed activity (either socially, at work or school, or sexually) or  
                psychomotor agitation (restlessness, pacing or holding multiple conversations at once) 
 
____ 7. Excessive involvement in pleasurable activities that have a high potential for painful  
consequences (e.g.,, engaging in unrestrained buying sprees, sexual indiscretions, or    
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